<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7571036</article-id><article-id pub-id-type="doi">10.3390/molecules25184145</article-id><article-id pub-id-type="publisher-id">molecules-25-04145</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Molecules Isolated from Mexican Hypoglycemic Plants: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7949-176X</contrib-id><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>Sonia Marlen</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04145">1</xref></contrib><contrib contrib-type="author"><name><surname>Mata</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="af2-molecules-25-04145">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1638-3443</contrib-id><name><surname>Andrade-Cetto</surname><given-names>Adolfo</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04145">1</xref><xref rid="c1-molecules-25-04145" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Milella</surname><given-names>Luigi</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-04145"><label>1</label>Laboratory of Etnofarmacology, Faculty of Sciences, National Autonomus University of Mexico, Mexico City 4510, Mexico; <email>soniaer@ciencias.unam.mx</email></aff><aff id="af2-molecules-25-04145"><label>2</label>Faculty of Chemistry, National Autonomus University of Mexico, Mexico City 4510, Mexico; <email>rachel@unam.mx</email></aff><author-notes><corresp id="c1-molecules-25-04145"><label>*</label>Correspondence: <email>aac@ciencias.unam.mx</email>; Tel.: +52-55-622-4834</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>25</volume><issue>18</issue><elocation-id>4145</elocation-id><history><date date-type="received"><day>15</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Like in many developing countries, in Mexico, the use of medicinal plants is a common practice. Based on our own field experience, there are at least 800 plants used for treating diabetes nowadays. Thus, their investigation is essential. In this context, this work aims to provide a comprehensive and critical review of the molecules isolated from Mexican hypoglycemic plants, including their source and target tested. In the last few years, some researchers have focused on the study of Mexican hypoglycemic plants. Most works describe the hypoglycemic effect or the mechanism of action of the whole extract, as well as the phytochemical profile of the tested extract. Herein, we analyzed 85 studies encompassing 40 hypoglycemic plants and 86 active compounds belonging to different classes of natural products: 28 flavonoids, 25 aromatic compounds, other than flavonoids, four steroids, 23 terpenoids, 4 oligosaccharides, and 1 polyalcohol. These compounds have shown to inhibit &#x003b1;-glucosidases, increase insulin secretion levels, increase insulin sensitivity, and block hepatic glucose output. Almost half of these molecules are not common metabolites, with a narrow taxonomic distribution, which makes them more interesting as lead molecules. Altogether, this analysis provides a necessary inventory useful for future testing of these active molecules against different hypoglycemic targets, to get a better insight into the already described mechanisms, and overall, to contribute to the knowledge of Mexican medicinal plants.</p></abstract><kwd-group><kwd>Mexican medicinal plants</kwd><kwd>hypoglycemic</kwd><kwd>&#x003b1;-glucosidase inhibitor</kwd><kwd>insulin sensitizer</kwd><kwd>insulin secretion</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-04145"><title>1. Introduction</title><p>Diabetes mellitus is a long-term condition that occurs when there are high glucose levels in a person&#x02019;s blood because their body cannot produce any or enough insulin or cannot effectively use the insulin it produces. Type 2 diabetes (T2D), due to a progressive loss of adequate &#x003b2;-cell insulin secretion frequently on the background of insulin resistance [<xref rid="B1-molecules-25-04145" ref-type="bibr">1</xref>], accounts for nearly 90% of cases. The International Diabetes Federation estimated 463.0 million people living with T2D worldwide, Mexico ranks in sixth place, with 12.8 million diabetics [<xref rid="B2-molecules-25-04145" ref-type="bibr">2</xref>]. Due to the idiosyncrasy of the Mexican population, normally, type 2 diabetic patients mainly in the rural areas of the country use a combination of medicinal plants and prescribed medicines [<xref rid="B3-molecules-25-04145" ref-type="bibr">3</xref>]. In Mexico, at least 300 plants have been reported as hypoglycemics [<xref rid="B4-molecules-25-04145" ref-type="bibr">4</xref>] but based on our own field experience [<xref rid="B5-molecules-25-04145" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-04145" ref-type="bibr">6</xref>], we estimate that at least 800 plants are used nowadays for treating diabetes.</p><p>Medicinal plants have been a resource for healing in local communities around the world. Still, 85% of the world&#x02019;s population depends on plants for primary healthcare [<xref rid="B7-molecules-25-04145" ref-type="bibr">7</xref>]. In addition, they are an important resource for drug discovery, with 80% of all synthetic drugs deriving from them [<xref rid="B8-molecules-25-04145" ref-type="bibr">8</xref>]. It is important to remark that medicinal plants can lead us to the discovery of new molecules useful for the development of new drugs for treating T2D and its complications.</p><p>Diverse strategies are utilized for control T2D; first, a combination of diet and exercise is in order; then, patients are prescribed oral hypoglycemic agents, initially a single drug, and later, a combination of two or more drugs. Patients can remain with exercise, diet, and oral hypoglycemic agents for a long time, providing they follow a healthy lifestyle. When this does not happen, they receive an oral hypoglycemic, first as monotherapy and then as a combination; if this does not control the blood glucose levels then external insulin is prescribed. The starting point for living well with diabetes is an early diagnosis, the longer a person lives with undiagnosed and untreated diabetes, the worse their health outcomes are likely to be. The World Health Organization (WHO) recommends a series of cost-effective interventions to improve patient outcomes. These interventions include blood glucose control through diet, physical activity, and, if necessary, medication [<xref rid="B9-molecules-25-04145" ref-type="bibr">9</xref>]. While the American Diabetes Association (ADA) remarks that lifestyle changes such as dietary modification and increased physical activity can be very effective in improving glycemic control, over the long-term, most individuals with T2D will require medications to achieve glycemic control [<xref rid="B10-molecules-25-04145" ref-type="bibr">10</xref>].</p><p>Until the beginning of the 1990s, sulfonylureas and metformin were the essential oral hypoglycemic agents available. Since then, new therapeutic agents have appeared in the pharmaceutical market. For example, acarbose, an alfa glucosidase inhibitor (AGI), was launched in Germany in 1990; the thiazolidinediones (TZD) insulin sensitizers, in 1996; exenatide, a glucagon-like peptide 1 (GLP1) receptor agonist, in 2005; sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, in 2006; and canagliflozin, a sodium&#x02013;glucose cotransporter 2 (SGLT-2) inhibitor, in 2013 [<xref rid="B11-molecules-25-04145" ref-type="bibr">11</xref>]. All these compounds have targets never described before. Acarbose and exenatide are natural products; other AGIs derive from natural products while metformin and canagliflozin are inspired by natural products. New targets to control hyperglycemia continuously appear, as we understand better the pathophysiology of T2D.</p><p>The research of traditional medicine can lead us to the discovery of new hypoglycemic compounds, associated with the traditional use of the plant. From an ethnopharmacological perspective, it is a start line to prove molecules isolated from plants traditionally used to treat T2D, although it is an intrinsically complex task demanding a highly sophisticated multidisciplinary approach.</p><p>In the last few years, some researchers have focused on the study of Mexican hypoglycemic plants. Most works describe the hypoglycemic effect or the mechanism of action of the whole extract, as well as the phytochemical profile of the tested extract. In the best of the cases, molecules are isolated from organic extracts but not tested against specific targets.</p><p>This work aims to provide a comprehensive and critical review of the molecules isolated from Mexican hypoglycemic plants. The studies analyzed included those reporting the hypoglycemic effect (i.e., any effect useful for potentially treating diabetes, in vivo or in vitro) of Mexican medicinal plants, and which possess at least one compound related to this activity. This review will be useful to construct a database useful for future testing of these molecules against different hypoglycemic targets.</p></sec><sec sec-type="results" id="sec2-molecules-25-04145"><title>2. Results</title><p>For this review, we selected and analyzed eighty-five works encompassing 40 hypoglycemic plants. Altogether, eighty-six active compounds were found, including 28 flavonoids, 25 aromatic compounds, other than flavonoids, 4 steroids, 23 terpenoids, 4 oligosaccharides, and 1 polyalcohol. <xref rid="molecules-25-04145-t001" ref-type="table">Table 1</xref> summarizes their natural sources, and <xref ref-type="fig" rid="molecules-25-04145-f001">Figure 1</xref>, <xref ref-type="fig" rid="molecules-25-04145-f002">Figure 2</xref>, <xref ref-type="fig" rid="molecules-25-04145-f003">Figure 3</xref> and <xref ref-type="fig" rid="molecules-25-04145-f004">Figure 4</xref> their corresponding structures. These compounds are representative of the major class metabolites of secondary metabolites from plants.</p><p>Among the flavonoids, the most abundant were flavonols (<bold>20</bold>, <bold>30</bold>, <bold>45</bold>&#x02013;<bold>47</bold>, <bold>62</bold>, <bold>169</bold>), glycosides or not, and flavones (<bold>21</bold>&#x02013;<bold>24</bold>, <bold>32</bold>, <bold>214</bold>&#x02013;<bold>216</bold>, <bold>229</bold>, <bold>231</bold>), although a few dihydrochalcones (<bold>96</bold>, <bold>102</bold>, <bold>80</bold>, <bold>93</bold>, <bold>99</bold>, <bold>104</bold>), a biflavone (<bold>208</bold>), a flavanone (<bold>55</bold>), and three flavan-3-ols (<bold>2, 113</bold>, <bold>204</bold>) are included. The aromatic compounds comprise eight coumarins, one simple (<bold>7</bold>), and seven 4-phenylcoumarins (<bold>106</bold>&#x02013;<bold>109</bold>, <bold>116</bold>, <bold>123</bold> and <bold>124</bold>); six hydroxycinnamic acids (<bold>3</bold>, <bold>13</bold>, <bold>27</bold>, <bold>112</bold>, <bold>217</bold>, <bold>232</bold>); three chromenes (<bold>39</bold>&#x02013;<bold>41</bold>); three depsides (<bold>120</bold>&#x02013;<bold>122</bold>); two phthalides (<bold>171</bold> and <bold>172</bold>); two &#x003b1;-pyrone glycosides (<bold>9</bold> and <bold>10</bold>); one stilbene (<bold>219</bold>); and one hydroxybenzoic acid (<bold>1</bold>). The terpenoids included 11 sesquiterpenes (<bold>4</bold>&#x02013;<bold>6</bold>, <bold>25, 26</bold>, <bold>42</bold>, <bold>43</bold>, <bold>175, 180</bold>, 1<bold>82</bold>, <bold>234</bold>), of which four were sesquiterpene lactones (<bold>25</bold>, <bold>42</bold>, <bold>43</bold>, <bold>175</bold>) of the eudesmanolide, heliangolides, and melampolides types; the remaining were a nor-sesquiterpene (<bold>234</bold>); one acyclic diol (<bold>26),</bold> two eremophylanes (<bold>180</bold>, <bold>182</bold>), and one bisabolene (<bold>4</bold>) and its rearranged products (<bold>5</bold>, <bold>6</bold>). Besides, one neo-clerodane diterpene (<bold>213</bold>); four limonoids (<bold>221</bold>, <bold>222</bold>, <bold>224</bold>, <bold>228</bold>); one cucurbitane (<bold>115</bold>); four oleananes (<bold>69</bold>, <bold>70, 188, 189</bold>); and two ursanes (<bold>11</bold> and <bold>118</bold>) completed the terpenoid family. Among the steroids, (<bold>12</bold>, <bold>31</bold>, <bold>33, 34)</bold>, compound <bold>12</bold> is unusual and has not been reported again from any natural source. The polyalcohol was the important cyclitol <bold>14</bold>, and the oligosaccharides (<bold>142</bold>, <bold>144</bold>, <bold>155</bold>, <bold>159</bold>) belong to the resin glycosides type (<xref ref-type="fig" rid="molecules-25-04145-f004">Figure 4</xref>).</p><p>The acute hypoglycemic effect was reported for 61 compounds: 19 Flavonoids (<bold>2, 20, 21</bold>&#x02013;<bold>24, 30, 32, 45</bold>&#x02013;<bold>47, 54, 55, 62, 104, 113, 169, 204, 214)</bold>, eight coumarins (<bold>7, 106</bold>&#x02013;<bold>109, 116, 123, 124</bold>) two pyrones (<bold>9</bold> and <bold>10</bold>), one depside (<bold>122</bold>), two phthalides (<bold>171</bold> and <bold>172</bold>), five phenylpropanoids (<bold>3, 13, 27, 112, 219)</bold>, nine sesquiterpenes (<bold>4</bold>&#x02013;<bold>6, 42, 43, 25, 180, 182, 234</bold>), two ursanes (<bold>11</bold> and <bold>118</bold>), three limonoids (<bold>221, 222, 224</bold>), one cucurbitane (<bold>115</bold>), four oleananes (<bold>69, 70, 188, 189</bold>) three steroids (<bold>12, 31, 33)</bold> and one ciclytol (<bold>14)</bold>. Eleven compounds displayed chronic hypoglycemic effect: Two flavonoids (<bold>2</bold> and <bold>20</bold>), five phenylcoumarins (<bold>106</bold>&#x02013;<bold>109, 116)</bold>, one cucurbitane (<bold>115</bold>), and three steroids (<bold>31, 33, 34</bold>).</p><p>Forty-four compounds inhibited &#x003b1;-glucosidases, in vivo and/or in vitro: 17 Flavonoids (<bold>2, 20, 45</bold>&#x02013;<bold>47, 21</bold>&#x02013;<bold>23, 54, 55, 113, 208, 214</bold>&#x02013;<bold>216, 229, 23)</bold>, three coumarin (<bold>7, 109, 116</bold>), three chromenes (<bold>39</bold>&#x02013;<bold>41</bold>), three depsides (<bold>120</bold>&#x02013;<bold>122</bold>), one phtalide (<bold>172</bold>), four phenylpropanoids (<bold>13, 27, 217, 232</bold>), eight sesquiterpenes (<bold>4</bold>&#x02013;<bold>6, 26, 42, 43, 175, 234</bold>) including three lactones, one diterpene (<bold>213</bold>) and, four oligosaccharides (<bold>142, 144, 155, 159</bold>). Nineteen compounds increase insulin levels: Eight flavonoids (<bold>2</bold>, <bold>20, 23, 24, 45</bold>&#x02013;<bold>47, 204</bold>), two phenylpropanoids (<bold>3</bold> and <bold>112</bold>), four sesquiterpenes (<bold>25, 180, 182, 234</bold>), three limonoids (<bold>221, 224, 228</bold>), one steroid (<bold>34</bold>) and one cucurbitane (<bold>115</bold>). Twenty compounds augmented insulin sensitivity: Nine flavonoids (<bold>2, 20, 23, 24, 45</bold>&#x02013;<bold>47, 113, 169</bold>), two phenylpropanoids (<bold>13</bold> and <bold>112</bold>), one hydroxybenzoic acid (<bold>1</bold>), seven terpenoids (<bold>70, 118, 188, 189, 221, 224, 228</bold>) and one steroid (<bold>34</bold>). Finally, nine compounds inhibit glucose 6-phosphatase activity: three flavonoids (<bold>20, 23, 24</bold>), two phenylpropanoids (<bold>13</bold> and <bold>112</bold>), one hydroxybenzoic acid (<bold>1</bold>), and three limonoids (<bold>221, 224, 228</bold>).</p><p>Thirteen compounds of the 86-active isolated from Mexican plants have been tested elsewhere. In most cases, the studies confirm the activity found in Mexico, as in the case of &#x003b1;-glucosidase inhibitors <bold>45</bold>, <bold>47</bold>, <bold>215</bold>, <bold>229</bold>, <bold>231</bold>, and <bold>232</bold>.</p><p><xref rid="molecules-25-04145-t002" ref-type="table">Table 2</xref> shows the complete list of compounds, the plant source, types of tests performed, and their mechanism of action. In addition, the activity of the compounds assessed elsewhere in the world is included. This is because, in many works, the mechanism of action of the compounds isolated from Mexican plants relies on the work performed by other authors.</p><p>It is important to mention that most compounds listed in <xref rid="molecules-25-04145-t001" ref-type="table">Table 1</xref>; <xref rid="molecules-25-04145-t002" ref-type="table">Table 2</xref> were isolated from organic extracts, and in a few cases from the traditionally aqueous preparation. Only in one case, the active principle of a hypoglycemic essential oil was established [<xref rid="B28-molecules-25-04145" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-04145" ref-type="bibr">29</xref>].</p><p>From the nine types of pharmacological agents currently used to treat T2D (sulfonylureas, meglitinides, biguanides, thiazolidinediones, alpha glucosidase inhibitors, DPP-4 inhibitors, bile acid sequestrants, dopamine agonists, and sodium&#x02013;glucose transport protein 2 inhibitors), the compounds obtained from Mexican hypoglycemic plants share one or more of their mechanisms of action. The mechanisms most frequently found were &#x003b1;-glucosidase inhibition, insulin secretion or sensitization, and/or inhibition of hepatic glucose output (HGO). The &#x003b1;-glucosidase inhibitory effect is clear from the assays; the hypoglycemic effect is only throughout the inhibition of the enzyme. In addition, the assays required to demonstrate the activity in vivo or in vitro are easier to perform. When the compounds increase insulin plasmatic levels, the mechanism action, however, is not straightforward because they can target the pancreatic &#x003b2;-cells, increase GLP1 production in the gut, inhibit DPP4, or even act through unknown mechanisms. Those behaving as insulin sensitizers might be affecting different pathways.</p><sec id="sec2dot1-molecules-25-04145"><title>2.1. Glucosidases Inhibitors</title><p>&#x003b1;-Glucosidase is the key enzyme involved in the digestion of carbohydrates; inhibitors of this enzyme can slow down the liberation of absorbable monosaccharides from dietary complex carbohydrates. The action mechanism of AGIs causes a decrease in glucose levels as well as osmotic effects. The disaccharides which are not digested will endure in the intestinal lumen and may lead to side effects such as diarrhea, flatulence, and abdominal pain [<xref rid="B122-molecules-25-04145" ref-type="bibr">122</xref>]. AGIs block the enzymatic reaction particularly because of their nitrogen component. Thus, they must be present at the site of enzymatic action at the same time as the carbohydrates. Three AGIs are now in therapeutic use worldwide; acarbose isolated from culture filtrates of <italic>Actinoplanes</italic>, was first described by Schmidt in 1977 and introduced onto the market in 1990; miglitol, a semisynthetic derivative of 1-deoxynojirimycin, from <italic>Bacillus</italic> and <italic>Streptomyces</italic> spp; and voglibose, which is prepared from validamycin A, a product of <italic>Streptomyces hygroscopicus</italic> [<xref rid="B84-molecules-25-04145" ref-type="bibr">84</xref>]. In Mexico, only acarbose is available.</p><p>While flavonoids and phenylpropanoids are well-known &#x003b1;-glucosidase inhibitors, depsides, phthalides, 4-phenylcoumarins, chromenes, &#x003b1;-pyrones, and sesquiterpene lactones are not. The most important AGIs isolated from Mexican plants are &#x003b1;-pipitzol (<bold>5</bold>), &#x003b2;-pipitzol (<bold>6</bold>), 6-acetyl-5-hydroxy-2,2-dimethyl-<italic>2H</italic>-chromene (<bold>39</bold>), calein A (<bold>42</bold>), calein C (<bold>43</bold>), 3-(<italic>Z</italic>)-butylidenephthalide (<bold>171</bold>), perfoliatin A (<bold>175</bold>), amarisolide (<bold>213</bold>), and pedalitin (<bold>214</bold>), and the 4-phenylcoumarins <bold>106</bold> and <bold>109</bold> (<xref rid="molecules-25-04145-t002" ref-type="table">Table 2</xref>). This ranking arose because these compounds showed in vivo and in vitro action. Some of them possessed other mechanisms as discussed later. Kinetic analysis indicated that 6-acetyl-5-hydroxy-2,2-dimethyl-<italic>2H</italic>-chromene (<bold>39</bold>) and calein C (<bold>43</bold>) behaved as noncompetititive and mixed (<italic>K</italic>i of 0.13 m) type inhibitors, respectively, against <italic>S. cerevisiae</italic> &#x003b1;-glucosidase [<xref rid="B28-molecules-25-04145" ref-type="bibr">28</xref>]. This behavior was consistent with the in silico predictions with AutoDock4, which revealed that <bold>43</bold> bound close to the catalytic site of the enzyme, with a <italic>K</italic>i value of 0.30 &#x003bc;M while compound <bold>39</bold> bound in regions different from the catalytic area, with a <italic>K</italic>i value of 13 &#x003bc;M. 3-(<italic>Z</italic>)-Butylidenephthalide (<bold>171</bold>), was also characterized as noncompetitive inhibitor with a <italic>K</italic>i of 4.86 mM [<xref rid="B67-molecules-25-04145" ref-type="bibr">67</xref>]. The 4-phenylcoumarins <bold>106</bold> and <bold>109</bold> were also good inhibitors of yeast &#x003b1;-glucosidase, but their aglycones were most active [<xref rid="B115-molecules-25-04145" ref-type="bibr">115</xref>]. Another unusual &#x003b1;-glucosidase inhibitor was the sesquiterpene salvinine (<bold>26</bold>), which behaved as a mixed type of inhibitor and because its size and properties form an interesting molecule for optimization to increase its potency [<xref rid="B22-molecules-25-04145" ref-type="bibr">22</xref>]. Perfoliatin (<bold>175</bold>) [<xref rid="B68-molecules-25-04145" ref-type="bibr">68</xref>] amarisolide (<bold>213</bold>), pedalitin (<bold>214</bold>) [<xref rid="B85-molecules-25-04145" ref-type="bibr">85</xref>] were not subjected to kinetic analysis but in silico analysis predicted that these compounds bind to yeast-&#x003b1;-glucosidase at the same site than acarbose.</p></sec><sec id="sec2dot2-molecules-25-04145"><title>2.2. Effect over Insulin Secretion</title><p>Different types of compounds increase insulin secretion. The first group described were the sulphonylureas, SUs, which stimulate the &#x003b2;-cells of the pancreas to release insulin. SUs binds to the SU receptor (SUR), a subunit of the potassium ATP-dependent (KATP) channels in the &#x003b2;-cell membrane, which eventually blocks the potassium channels and facilitates the influx of Ca<sup>2+</sup> into the cell, leading to membrane depolarization and subsequently insulin exocytosis. The main side effect is hypoglycemia; in Mexico, the most used SU is glibenclamide [<xref rid="B123-molecules-25-04145" ref-type="bibr">123</xref>].</p><p>The glinides include drugs such as repaglinide (the only one available in Mexico), which belong to the group of nonsulfonylurea insulin secretagogues, with a rapid onset and reduced interval of action. They act by binding to the SUR1 receptor of the pancreatic &#x003b2;-cells (in a different site than SUs), they have less affinity for the receptor in comparison to SUs. Unfortunately, the glinides produce many adverse effects such as nausea, vomiting, diarrhea, constipation, gastrointestinal upsets, and abdominal pain. Due to their short duration of action, the associated hypoglycemia is much less recurrent than SUs [<xref rid="B124-molecules-25-04145" ref-type="bibr">124</xref>].</p><p>Incretin-based medicines; after the intake of oral glucose, a phenomenon called incretin effect occurs, which increases insulin secretion up to 50&#x02013;70%. The incretin hormones, Glucagon-like peptide-1 (GLP-1) and the glucose-dependent insulinotropic polypeptide (GIP) are intestinal peptides released after ingestion of food; they augment the pancreatic islet function by increasing insulin release and suppressing the synthesis of glucagon. The incretin-based medications include two classes of drugs, dipeptidyl peptidase-4 (DPP-4) inhibitors and GLP-1 receptor agonists. Both medications diminished the glycemic abnormalities. The incretin hormones GLP-1 and GIP inhibited gastric emptying, decreased appetite and food intake, and reduced glucagon&#x02019;s secretion. The life span of GLP-1 is very short, as DPP-4 converts GLP-1 into an inactive form. While DPP-4 inhibitors increase the life span of the incretin hormones, the GLP1 agonists imitate the glucoregulatory actions of GLP-1 and diminish the release of glucagon, thus improving the glucose-dependent secretion of insulin. At the same time, common symptoms associated with the use of GLP-1 receptor agonists include gastrointestinal symptoms, mainly nausea and vomiting, headaches, reactions at the site of injection, and nasopharyngitis [<xref rid="B125-molecules-25-04145" ref-type="bibr">125</xref>,<xref rid="B126-molecules-25-04145" ref-type="bibr">126</xref>]. In Mexico, exenatide (a GLP1 agonist) is available as well as the DPP-4 inhibitor (sitagliptin).</p><p>Based on the reported experiments, a few molecules isolated from Mexican plants can increase insulin levels; the most common were again phenylpropanoids and flavonoids. The first group includes the phenylpropanoids <italic>&#x003c1;</italic>-coumaric acid (<bold>3</bold>) and caffeic acid (<bold>112</bold>). The relevant flavonoids were eupatilin (<bold>23</bold>) and jaceosidin (<bold>24</bold>) which increased insulin secretion with no specific mechanism; but with the involvement of K<sup>+</sup>-ATP sensitive and Ca<sup>2+</sup>-voltage-dependent channels, which play an important role in insulin secretion [<xref rid="B21-molecules-25-04145" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-04145" ref-type="bibr">22</xref>]. The flavonol kaempferol (<bold>46</bold>) restores PA-induced loss of &#x003b2;-cell mass and function through AMPK/mTOR-mediated autophagy. Finally, cinchonain 1b (<bold>204</bold>) induces insulin secretion in vitro and in vivo.</p><p>More unusual were 3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-23,24-dihydrocucurbitacin F (<bold>115</bold>), 5-<italic>O</italic>-<sc>d</sc>-glucopyranosyl-7-3&#x02032;,4&#x02032;-triihydroxy-4-phenylcoumarin (<bold>109</bold>), 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-apiofuranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;, 4&#x02032;-dihydroxy-4-phenyl-coumarin (<bold>116</bold>) and other 4-phenylcoumarins, which increase insulin secretion in rats [<xref rid="B55-molecules-25-04145" ref-type="bibr">55</xref>]. Compounds <bold>109</bold> and <bold>116</bold> stimulated AMPK phosphorylation in vitro in C2C12 myoblast cells. Thus, these compounds activate the AMPK pathway, which, in turn, could stimulate insulin secretion [<xref rid="B127-molecules-25-04145" ref-type="bibr">127</xref>]. Based on these structures, Wang and collaborators in 2017 [<xref rid="B128-molecules-25-04145" ref-type="bibr">128</xref>] synthesized a few substituted 4-phenylcoumarins derivatives analogs of compound <bold>109</bold>; their pharmacological investigation showed that those 4-phenylcoumarins possessing adjacent 7,8-dihydroxy groups were equipotent to the standard drug glibenclamide as hypoglycemic agents in vivo. In addition, these compounds inhibited aldose reductase and advanced glycation end-product formation. Altogether, this shows the potential of 4-phenylcoumarins for the development of therapeutic agents for treating diabetes, and how products discovered during the investigation of Mexican hypoglycemic plants are useful as templates for the development of more active compounds [<xref rid="B128-molecules-25-04145" ref-type="bibr">128</xref>]. The sesquiterpene lactone arglanin (<bold>25</bold>) was investigated as a hypoglycemic agent in Mexico for the first time. Its nonspecific mechanisms also involved K<sup>+</sup>-ATP sensitive and Ca<sup>2+</sup>-voltage-dependent channels [<xref rid="B22-molecules-25-04145" ref-type="bibr">22</xref>]. Finally, the cyclitol <sc>l</sc>-<italic>chiro</italic>-inositol (<bold>14)</bold>, is also a well-known hypoglycemic agent. Inositol derivatives (among them compound <bold>14</bold>), have been reported to help the action of insulin stimulating glucose uptake in skeletal muscle cells, so they also work as insulin sensitizers [<xref rid="B18-molecules-25-04145" ref-type="bibr">18</xref>,<xref rid="B129-molecules-25-04145" ref-type="bibr">129</xref>].</p></sec><sec id="sec2dot3-molecules-25-04145"><title>2.3. Insulin Sensitizers</title><p>As mentioned above, T2D has two main components, insulin resistance and a progressive failure in insulin secretion. Insulin Resistance (IR) leads to a loss of response from the peripheral insulin target tissues (mainly the liver, adipose, and muscle tissues) to insulin. IR impairs the ability of the pancreatic cells to synthesize and secrete enough insulin to address the metabolic needs of the body. Insulin sensitizers help target cells in liver, skeletal muscle, and adipose tissue to respond properly to insulin, resulting in their ability to efficiently uptake and metabolize glucose [<xref rid="B130-molecules-25-04145" ref-type="bibr">130</xref>].</p><p>Glitazones (TZDs) are insulin sensitizers used for treating T2D. TZDs are selective agonists of PPAR&#x003b3;, a transcription factor involved in the regulation of the expression of specific genes present in fat cells and other tissues. TZDs primarily act in adipose tissue where expression of PPAR&#x003b3; predominates. They interfere with the expression and release of mediators of IR (e.g., free fatty acids, adipocytokines, resistin, adiponectin) that originate in adipose tissue, thus resulting in improvement of insulin sensitivity in muscle and liver [<xref rid="B131-molecules-25-04145" ref-type="bibr">131</xref>]. Treatment with TZDs might produce adverse hepatic, cardiovascular, osteological, and carcinogenic events [<xref rid="B132-molecules-25-04145" ref-type="bibr">132</xref>]; therefore, TZDs were withdrawn for the market in several European countries; in Mexico, rosiglitazone is still available. Because of the importance of insulin sensitizers in the treatment of T2D, new-generation insulin sensitizers classified as direct PPAR&#x003b3; agonists, selective PPAR&#x003b3; modulators, and PPAR&#x003b3;-sparing compounds are in development [<xref rid="B130-molecules-25-04145" ref-type="bibr">130</xref>].</p><p>Some important molecules acting as insulin sensitizers, but with an unknown mechanism, isolated from Mexican plants are: Protocatechuic acid (<bold>1</bold>), catechin (<bold>2</bold>) oleanolic acid (<bold>70</bold>), and epicatechin (<bold>113</bold>), for these molecules, the HOMA has been calculated. Acacetin (<bold>21</bold>) and diosmetin (<bold>22</bold>) are PPAR agonists. Isorhamnetin (<bold>45</bold>) and quercetin (<bold>47</bold>) increase glucose uptake in skeletal muscle by activation of the JAK/STAT pathway, and CaMKK&#x003b2;/AMPK and insulin signaling pathways, respectively. Kaempferitrin (<bold>169</bold>) inhibits GLUT4 mediated glucose uptake in differentiated 3T3-L1 cells by interfering with the insulin signaling pathway and by directly interacting with membrane GLUT4. &#x003b2;-sitosterol (<bold>34</bold>) attenuates the insulin receptor substrate-1 serine phosphorylation. However, it up-regulates RNA expression of IR and postreceptor insulin signaling molecules such as IRS-1, &#x003b2;-arrestin 2, Akt, AS160, and GLUT4 with a concomitant increase in the levels of IRS-1, p-IRS1-1, Akt, p-Akt, AS160, and p-AS160 compared with type-2 diabetic rats [<xref rid="B118-molecules-25-04145" ref-type="bibr">118</xref>]. Finally, 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-apiofuranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenyl-coumarin (<bold>116</bold>) stimulated <sup>3</sup>H-deoxyglucose uptake in C2C12 myoblasts cells after 18 h of incubation. The effect was like metformin and insulin and was concentration-dependent [<xref rid="B59-molecules-25-04145" ref-type="bibr">59</xref>].</p></sec><sec id="sec2dot4-molecules-25-04145"><title>2.4. Inhibitors of Hepatic Glucose Output (HGO)</title><p>One important action of insulin is the signaling over the liver when there is not enough insulin or there is some degree of insulin resistance in the hepatic cell, the result is an augmentation of glucose output. The liver plays a crucial role in maintaining blood glucose levels during fasting by converting its stored glycogen to glucose (glycogenolysis) and by synthesizing glucose, mainly from pyruvate and amino acids (gluconeogenesis) [<xref rid="B133-molecules-25-04145" ref-type="bibr">133</xref>].</p><p>In T2D subjects with mild to moderate fasting hyperglycemia (140&#x02013;200 mg/dL), basal hepatic glucose production increases by ~0.5 mg/kg min. Consequently, during the overnight sleeping hours (22.00 to 8.00 h), the liver of an 80 kg diabetic individual with modest fasting hyperglycemia adds 35 g of glucose to the systemic circulation. In T2D, insulin resistance in the liver reflects hyperinsulinemia&#x02019;s failure to suppress gluconeogenesis, resulting in fasting hyperglycemia and decreased liver glycogen storage in the postprandial state. Increased hepatic glucose production occurs early during diabetes, although the increase is more obvious after the onset of insulin secretory abnormalities and insulin resistance in skeletal muscle. T2D is characterized by impaired glucose homeostasis partly due to abnormally elevated HGO [<xref rid="B134-molecules-25-04145" ref-type="bibr">134</xref>].</p><p>Metformin, the main insulin sensitizer in use worldwide, acts by different mechanisms, diminishing the intestinal glucose absorption, increasing peripheral uptake and use of glucose, and lowering the hepatic synthesis of glucose [<xref rid="B122-molecules-25-04145" ref-type="bibr">122</xref>]. Although metformin is an insulin sensitizer, its action over the HGO is also significant; metformin induces mild energy stress in the liver, leading to an increase in AMP concentration that allosterically inhibits the enzyme fructose-1,6-bisphosphatase-(FBP1) to lower HGO. This is a very important mechanism, as the subsequent increase in F-1,6-P2, will activate PK and increase glycolytic flux. Because AMP-inhibited FBP1, a rate-controlling enzyme in gluconeogenesis, it functions as a major contributor to the therapeutic action of metformin [<xref rid="B135-molecules-25-04145" ref-type="bibr">135</xref>].</p><p>Although in the international literature, polyphenols like kaempferol or caffeic acid have been related to the blockage of the enzyme G6Pase, from Mexican plants, chlorogenic acid a well-characterized inhibitor of the G6Pase T1 translocase system [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>]; thus, it can block HGO, has been reported. <italic>&#x003c1;</italic>-Coumaric acid (<bold>3</bold>) inhibits fructose-1,6-bisphosphatase, which also leads to the block of HGO; however, this mechanism has not been explored in molecules isolated from Mexican plants.</p><p>The limonoids 2-hydroxy-destigloyl-6-deoxyswietenine acetate (<bold>221),</bold> methyl-2-hydroxy-3-&#x003b2;-tigloyloxy-1-oxomeliac-8(30)-enate (<bold>223</bold>), and humilinolide H (<bold>228</bold>), isolated from <italic>S. humilis</italic>, inhibit also glucose-6-phosphatase, representing new leads for further exploration as HGO, agents. The complexity of their structure makes them good candidates for fragment-based drug discovery.</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-25-04145"><title>3. Discussion</title><p>T2D is an important health problem in many countries; Mexico is not an exception. Like in many developing countries, in Mexico the use of medicinal plants is a common practice, for these two main reasons, plants play an essential role in how the Mexican population treats T2D, this situation is beside the institutional medical attention. It is important to understand how these plants produce a hypoglycemic effect for future isolation of promissory molecules for the development of new hypoglycemic agents.</p><p>In the present manuscript, we document 86 molecules isolated from Mexican plants, intending to provide a necessary inventory for further studies. Almost half of these molecules are not common metabolites, with a narrow taxonomic distribution, which makes them more interesting as lead molecules. Some of the most complex molecules (i.e., the limonoids, cucurbitans, or the oligosaccharides) are good candidates for fragment-based drug discovery. The studies summarized in <xref rid="molecules-25-04145-t001" ref-type="table">Table 1</xref> and <xref rid="molecules-25-04145-t002" ref-type="table">Table 2</xref> along with chemical informatics methods and network pharmacology provides useful information for the development of new phytopharmaceutical preparations. In addition, because some of these molecules are present in plants worldwide, <xref rid="molecules-25-04145-t002" ref-type="table">Table 2</xref> will be a useful reference for promoting the testing of these compounds in other targets, known or news, and a better insight into the already described mechanisms.</p><p>When hypoglycemic plants are studied it is imperative to set the goal of the study; one point is to prove if the plant has a hypoglycemic effect, which can explain the traditional use but another point is to escalate the study to produce a phytomedicine or a single isolated compound, like metformin. The fact that a plant possesses a hypoglycemic effect does not necessarily mean that it will be of clinical use; for this reason, it is essential to study single molecules in known and new pharmacological targets, aiming to have novel hypoglycemic agents of clinical relevance.</p><p>In recent years, the investigation of medicinal plants used to treat diabetes in Mexico has improved. However, we still need to achieve the final goal, contributing with a hypoglycemic agent or phytomedicines of significant clinical efficacy; we are just in the initial steps documenting hypoglycemic plants, and progressing in preclinical testing. The works have been narrowed in scope, both from the pharmacological and chemical point of view. The number and diversity of small molecules to address all the different binding sites in the complex biology of diabetes are still awaiting to be isolated from the plants in <xref rid="molecules-25-04145-t001" ref-type="table">Table 1</xref>, and other plants yet to be discovered. The essential oils of these plants, plenty of small molecules suitable for the development of hypoglycemic agents remain unexplored. The constituents of the essential oils offer good prospects for drug discovery. These constituents meet most conditions required for good drug candidates and offer attractive opportunities for lead optimization or even fragment-based drug discovery. New technologies such as metabolomics can accelerate dereplication and identification of compounds with novel skeletons; routine incorporation of protein&#x02013;metabolite interaction and cell-based assays, which require small amounts of samples are essential.</p><p>Most compounds in <xref rid="molecules-25-04145-t001" ref-type="table">Table 1</xref> require testing as glucose reabsorption inhibitors, incretin analogs, DDP4 blockers, bile acid sequestrants, or dopamine agonists. The effect of these molecules over gut microbiota also needs attention since these bacteria play an important role in the control of T2D. We consider essential to test these molecules as glucose reabsorption inhibitors in the kidney because many plants traditionally used for treating T2D are also employed to treat &#x0201c;Mal de Orin&#x0201d;, an entity that people detect when you have urination problems; this type of plants augment the urine flux. The inhibition of hepatic glucose output is also an important target to assess. From there compounds with similar actions like metformin could upsurge.</p><p>A single molecule can have more than one mechanism of action. This might be targeting different proteins within the same (network pharmacology) or different (polypharmacology) signaling pathways In the context, of a botanical mixture, a pool of molecules, perhaps in low concentrations, acting by biochemical synergism can lead to the desired effect, hypoglycemic action, without the presence of a major highly bioactive compound. This has been the classic paradigm of phytotherapy. The advantages of dealing with polyvalent drugs are a decrease of drug-drug interactions, less cost for the patient to bear, increased adherence due to lower side effects, the possibility of treating concomitant diseases, just to mention a few. In this review, we found some examples of compounds possessing more than one mechanism. Thus, protocatechuic acid (<bold>1</bold>) is an insulin sensitizer and secretagogue. Quercetin (<bold>47</bold>) is an insulin sensitizer and secretagogue, as well as the inhibitor of &#x003b1;-glucosidases. Epicatechin (<bold>113</bold>) inhibits &#x003b1;-glucosidase and behaves as an insulin sensitizer. Kaempferol (<bold>46</bold>) inhibits hepatic gluconeogenesis, is an insulin sensitizer and inhibits &#x003b1;-glucosidases. Caffeic acid (<bold>112</bold>) induces insulin secretion, decreases hepatic glucose output, inhibits alpha glucosidases, and is an insulin sensitizer. Furthermore, 2-Hydroxy-destigloyl-6-deoxyswietenine acetate (<bold>221</bold>) stimulates insulin secretion due to a partial blockade of K<sup>+</sup>-ATP channels, and a serotonergic modulation on 5-HT2 receptors inhibited hepatic glucose-6-phosphatase, and stimulated muscle glucose uptake and basal oxygen consumption in muscle cells [<xref rid="B91-molecules-25-04145" ref-type="bibr">91</xref>]. The 4-phenylcoumaris affects glucose absorption, insulin secretion, and glucose utilization. With these examples, we want to remark the importance of testing 86 described compounds over different action mechanisms.</p></sec><sec id="sec4-molecules-25-04145"><title>4. Materials and Methods</title><p>This study was performed based on the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) [<xref rid="B136-molecules-25-04145" ref-type="bibr">136</xref>]. To obtain pertinent literature, without author bias, peer-reviewed research articles were obtained from the following databases: PubMed, MEDLINE, EMBASE, SCOPUS, SciFinder, and Clarivate Analytics. Inclusion criteria were studies reporting the hypoglycemic effect of Mexican medicinal plants, and at least one pure compound was isolated and selected.</p></sec><sec sec-type="conclusions" id="sec5-molecules-25-04145"><title>5. Conclusions</title><p>The use of medicinal plants to manage diabetes is an overwhelming reality that requires being set into the correct health care perspective. Indeed, these plants will keep providing promissory agents for the development of new antidiabetic drugs or phytotherapeutic products. In this review, we summarize new and known hypoglycemic agents from the reported Mexican hypoglycemic plants. These compounds represent only a small fraction of the chemical space of Mexican Medicinal plants. Some of the compounds&#x02019; scaffolds are common, in particular those of the phenylpropanoids and flavonoids. Among the terpenoids and steroids, the ursanes and stigmastanes are widespread in nature, while the remaining terpenoids are less common and restricted to some genus of some family plants. Finally, the other aromatic compounds and the resin glycosides are also limited to a few vegetal species. Except for the flavonoids and phenylpropanoids, the hypoglycemic properties and/or the chemical structures of most compounds were discovered in Mexico, following an ethnopharmacological hypothesis. Their mechanisms of actions involved inhibition of &#x003b1;-glucosidase, insulin secretion or sensitization, and/or inhibition of hepatic glucose output. Some of the less common compounds are multitarget which makes them attractive for drug development.</p></sec></body><back><notes><title>Author Contributions</title><p>S.M.E.-R.; Performed the bibliographic research summarized in tables and figures. R.M. and A.A.-C., equally contributed to writing the manuscript. A.A.-C. envisioned the review. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This project was partially sponsored by DGAPA (PAPIIT IN226719, PAPIIT IN 217320) and CONACyT CB A1-S-11226.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-04145"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association 2</collab></person-group><article-title>Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes&#x02014;2020</article-title><source>Diabetes Care</source><year>2019</year><volume>43</volume><fpage>S14</fpage><lpage>S31</lpage><pub-id pub-id-type="doi">10.2337/dc20-S002</pub-id></element-citation></ref><ref id="B2-molecules-25-04145"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carracher</surname><given-names>A.M.</given-names></name><name><surname>Marathe</surname><given-names>P.H.</given-names></name><name><surname>Close</surname><given-names>K.L.</given-names></name></person-group><article-title>International Diabetes Federation 2017</article-title><source>J. Diabetes</source><year>2018</year><volume>10</volume><fpage>353</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12644</pub-id><?supplied-pmid 29345068?><pub-id pub-id-type="pmid">29345068</pub-id></element-citation></ref><ref id="B3-molecules-25-04145"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Becerra-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Mart&#x000ed;nez-Zurita</surname><given-names>E.</given-names></name><name><surname>Ortega-Larrocea</surname><given-names>M.P.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Disease-Consensus Index as a tool of selecting potential hypoglycemic plants in Chikindzonot, Yucat&#x000e1;n, M&#x000e9;xico</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>107</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.03.005</pub-id><pub-id pub-id-type="pmid">16621373</pub-id></element-citation></ref><ref id="B4-molecules-25-04145"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Mexican plants with hypoglycaemic effect used in the treatment of diabetes</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>99</volume><fpage>325</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.04.019</pub-id><pub-id pub-id-type="pmid">15964161</pub-id></element-citation></ref><ref id="B5-molecules-25-04145"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>E.C.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Ethnopharmacological field study of the plants used to treat type 2 diabetes among the Cakchiquels in Guatemala</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>159</volume><fpage>238</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.11.021</pub-id><pub-id pub-id-type="pmid">25460591</pub-id></element-citation></ref><ref id="B6-molecules-25-04145"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Ethnobotanical study of the medicinal plants from Tlanchinol, Hidalgo, M&#x000e9;xico</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>122</volume><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.12.008</pub-id><pub-id pub-id-type="pmid">19146936</pub-id></element-citation></ref><ref id="B7-molecules-25-04145"><label>7.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>P&#x0011b;s&#x000ed;c</surname><given-names>M.</given-names></name></person-group><article-title>Development of Natural Product Drugs in A Sustainable Manner</article-title><source>GDSR</source><year>2015</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://sustainabledevelopment.un.org/content/documents/6544118_Pesic_Developmentofnaturalproductdrugsinasustainablemanner.pdf">https://sustainabledevelopment.un.org/content/documents/6544118_Pesic_Developmentofnaturalproductdrugsinasustainablemanner.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B8-molecules-25-04145"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>A.</given-names></name><name><surname>Broenstrup</surname><given-names>M.</given-names></name></person-group><article-title>Industrial natural product chemistry for drug discovery and development</article-title><source>Nat. Prod. Rep.</source><year>2014</year><volume>31</volume><fpage>35</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1039/C3NP70058E</pub-id><pub-id pub-id-type="pmid">24142193</pub-id></element-citation></ref><ref id="B9-molecules-25-04145"><label>9.</label><element-citation publication-type="web"><article-title>World Health Organisation (WHO) Diabetes</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-topics/diabetes#tab=tab_3">https://www.who.int/health-topics/diabetes#tab=tab_3</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B10-molecules-25-04145"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association 5</collab></person-group><article-title>Lifestyle management: Standards of medical care in diabetes&#x02014;2019</article-title><source>Diabetes Care</source><year>2018</year><volume>42</volume><fpage>S46</fpage><lpage>S60</lpage><pub-id pub-id-type="doi">10.2337/dc19-s005</pub-id></element-citation></ref><ref id="B11-molecules-25-04145"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J.R.</given-names></name></person-group><article-title>A Brief history of the development of diabetes medications</article-title><source>Diabetes Spectr.</source><year>2014</year><volume>27</volume><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.2337/diaspect.27.2.82</pub-id><pub-id pub-id-type="pmid">26246763</pub-id></element-citation></ref><ref id="B12-molecules-25-04145"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-M&#x000e9;ndez</surname><given-names>A.J.</given-names></name><name><surname>Carmen-Sandoval</surname><given-names>W.</given-names></name><name><surname>Lomas-Soria</surname><given-names>C.</given-names></name><name><surname>Guevara-Gonzalez</surname><given-names>R.G.</given-names></name><name><surname>Reynoso-Camacho</surname><given-names>R.</given-names></name><name><surname>Villagran-Herrera</surname><given-names>M.E.</given-names></name><name><surname>Salazar-Olivo</surname><given-names>L.A.</given-names></name><name><surname>Torres-Pacheco</surname><given-names>I.</given-names></name><name><surname>Feregrino-Perez</surname><given-names>A.A.</given-names></name></person-group><article-title>Timbe (<italic>Acaciella angustissima</italic>) pods extracts reduce the levels of glucose, insulin and improved physiological parameters, hypolipidemic effect, oxidative stress and renal damage in streptozotocin-induced diabetic rats</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2812</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23112812</pub-id></element-citation></ref><ref id="B13-molecules-25-04145"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>A.L.</given-names></name><name><surname>Madariaga-Maz&#x000f3;n</surname><given-names>A.</given-names></name><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antidiabetic and antihyperalgesic effects of a decoction and compounds from <italic>Acourtia thurberi</italic></article-title><source>Planta Med.</source><year>2016</year><volume>83</volume><fpage>534</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1055/s-0042-119652</pub-id><pub-id pub-id-type="pmid">27824405</pub-id></element-citation></ref><ref id="B14-molecules-25-04145"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Pyrone glycosides from <italic>Acosmium panamense</italic> (Benth.) Yacovlev</article-title><source>Zeitschrift f&#x000fc;r Naturforschung C</source><year>2003</year><volume>58</volume><fpage>637</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1515/znc-2003-9-1006</pub-id><?supplied-pmid 14577622?><pub-id pub-id-type="pmid">14577622</pub-id></element-citation></ref><ref id="B15-molecules-25-04145"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Acosmium panamense</italic> bark on streptozotocin diabetic rats</article-title><source>J. Ethnopharmacol.</source><year>2004</year><volume>90</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.09.049</pub-id><?supplied-pmid 15013183?><pub-id pub-id-type="pmid">15013183</pub-id></element-citation></ref><ref id="B16-molecules-25-04145"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>G.R.M.</given-names></name><name><surname>Perez</surname><given-names>G.S.</given-names></name><name><surname>Zavala</surname><given-names>M.A.</given-names></name><name><surname>Perez</surname><given-names>G.S.C.</given-names></name></person-group><article-title>Effect of <italic>Agarista mexicana</italic> and <italic>Verbesina persicifolia</italic> on blood glucose level of normoglycaemic and alloxan-diabetic mice and rats</article-title><source>Phytother. Res.</source><year>1996</year><volume>10</volume><fpage>351</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1573(199606)10:4&#x0003c;351::AID-PTR837&#x0003e;3.0.CO;2-J</pub-id></element-citation></ref><ref id="B17-molecules-25-04145"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>G.R.M.</given-names></name><name><surname>Solis</surname><given-names>R.V.</given-names></name></person-group><article-title>Triterpenes from <italic>Agarista mexicana</italic> as potential antidiabetic agents</article-title><source>Phytother. Res.</source><year>2002</year><volume>16</volume><fpage>55</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/ptr.966</pub-id><?supplied-pmid 11807966?><pub-id pub-id-type="pmid">11807966</pub-id></element-citation></ref><ref id="B18-molecules-25-04145"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustos-Brito</surname><given-names>C.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Giraldo-Aguirre</surname><given-names>J.D.</given-names></name><name><surname>Moreno-Vargas</surname><given-names>A.D.</given-names></name><name><surname>Quijano</surname><given-names>L.</given-names></name></person-group><article-title>Acute hypoglycemic effect and phytochemical composition of <italic>Ageratina petiolaris</italic></article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>185</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.03.048</pub-id><pub-id pub-id-type="pmid">27013093</pub-id></element-citation></ref><ref id="B19-molecules-25-04145"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata-Torres</surname><given-names>G.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Espinoza-Hern&#x000e1;ndez</surname><given-names>F.A.</given-names></name><name><surname>C&#x000e1;rdenas-V&#x000e1;zquez</surname><given-names>R.</given-names></name></person-group><article-title>Hepatic glucose output inhibition by Mexican plants used in the treatment of Type 2 Diabetes</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.00215</pub-id><pub-id pub-id-type="pmid">31998136</pub-id></element-citation></ref><ref id="B20-molecules-25-04145"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>F.</given-names></name><name><surname>Solares-Pascasio</surname><given-names>J.I.</given-names></name><name><surname>Ordo&#x000f1;ez-Razo</surname><given-names>R.M.</given-names></name><name><surname>Vel&#x000e1;zquez</surname><given-names>C.</given-names></name><name><surname>Barbosa</surname><given-names>E.</given-names></name><name><surname>Garc&#x000ed;a-Hern&#x000e1;ndez</surname><given-names>N.</given-names></name><name><surname>Mendez-Luna</surname><given-names>D.</given-names></name><name><surname>Correa-Basurto</surname><given-names>J.</given-names></name></person-group><article-title>Antihyperglycemic Activity of the Leaves from <italic>Annona cherimola</italic> Miller and Rutin on Alloxan-induced Diabetic Rats</article-title><source>Pharmacogn. Res.</source><year>2017</year><volume>9</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.4103/0974-8490.199781</pub-id><?supplied-pmid 28250646?><pub-id pub-id-type="pmid">28250646</pub-id></element-citation></ref><ref id="B21-molecules-25-04145"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju&#x000e1;rez-Reyes</surname><given-names>K.</given-names></name><name><surname>Brindis</surname><given-names>F.</given-names></name><name><surname>Medina-Campos</surname><given-names>O.N.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycemic, antihyperglycemic, and antioxidant effects of the edible plant <italic>Anoda cristata</italic></article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>161</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.11.052</pub-id><pub-id pub-id-type="pmid">25490313</pub-id></element-citation></ref><ref id="B22-molecules-25-04145"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaya-Eugenio</surname><given-names>G.D.</given-names></name><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name><name><surname>Rivera-Ch&#x000e1;vez</surname><given-names>J.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycemic properties of some preparations and compounds from <italic>Artemisia ludoviciana</italic> Nutt</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>155</volume><fpage>416</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.05.051</pub-id><pub-id pub-id-type="pmid">24892833</pub-id></element-citation></ref><ref id="B23-molecules-25-04145"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Galicia</surname><given-names>M.C.</given-names></name><name><surname>Burgue&#x000f1;o-Tapia</surname><given-names>E.</given-names></name><name><surname>Romero-Rojas</surname><given-names>A.</given-names></name><name><surname>Garc&#x000ed;a-Zebad&#x000fa;a</surname><given-names>J.C.</given-names></name><name><surname>Cornejo-Garrido</surname><given-names>J.</given-names></name><name><surname>Ordaz-Pichardo</surname><given-names>C.</given-names></name></person-group><article-title>Anti-hyperglycemic effect, inhibition of inflammatory cytokines expression, and histopathology profile in streptozotocin-induced diabetic rats treated with <italic>Arracacia tolucensis</italic> aerial-parts extracts</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>152</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.12.031</pub-id><?supplied-pmid 24373809?><pub-id pub-id-type="pmid">24373809</pub-id></element-citation></ref><ref id="B24-molecules-25-04145"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Espinosa</surname><given-names>F.</given-names></name><name><surname>D&#x000e9;ciga-Campos</surname><given-names>M.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antinociceptive, hypoglycemic and spasmolytic effects of <italic>Brickellia veronicifolia</italic></article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>118</volume><fpage>448</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.05.012</pub-id><?supplied-pmid 18583074?><pub-id pub-id-type="pmid">18583074</pub-id></element-citation></ref><ref id="B25-molecules-25-04145"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>G.R.M.</given-names></name><name><surname>Cervantes</surname><given-names>C.H.</given-names></name><name><surname>Zavala</surname><given-names>S.M.A.</given-names></name><name><surname>Sanchez</surname><given-names>A.J.</given-names></name><name><surname>Perez</surname><given-names>G.S.</given-names></name><name><surname>Perez</surname><given-names>G.C.</given-names></name></person-group><article-title>Isolation and hypoglycemic activity of 5, 7,3&#x02032;-trihydroxy-3,6,4&#x02032;-trimethoxyflavone from <italic>Brickellia veronicaefolia</italic></article-title><source>Phytomedicine</source><year>2000</year><volume>7</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(00)80018-5</pub-id><pub-id pub-id-type="pmid">10782487</pub-id></element-citation></ref><ref id="B26-molecules-25-04145"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Medina-Hern&#x000e1;ndez</surname><given-names>A.E.B.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Bromelia plumieri</italic> (E. Morren) L.B. Sm., leaves in STZ-NA-induced diabetic rats</article-title><source>Front. Pharmacol.</source><year>2013</year><volume>4</volume><pub-id pub-id-type="doi">10.3389/fphar.2013.00036</pub-id></element-citation></ref><ref id="B27-molecules-25-04145"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>S&#x000e1;nchez-Villase&#x000f1;or</surname><given-names>G.</given-names></name></person-group><article-title>Phytochemical composition and chronic hypoglycemic effect of <italic>bromelia karatas</italic> on STZ-NA-induced diabetic rats</article-title><source>Evid. Based Complementary Altern. Med.</source><year>2019</year><volume>2019</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2019/9276953</pub-id></element-citation></ref><ref id="B28-molecules-25-04145"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>&#x003b1;-Glucosidase inhibitors from <italic>Brickellia cavanillesii</italic></article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>968</fpage><lpage>974</lpage><comment>reprint in <italic>J. Nat. Prod.</italic><bold>2017</bold>, <italic>80</italic>, 233</comment><pub-id pub-id-type="doi">10.1021/np300204p</pub-id><pub-id pub-id-type="pmid">22587572</pub-id></element-citation></ref><ref id="B29-molecules-25-04145"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>P&#x000e9;rez-V&#x000e1;squez</surname><given-names>A.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>M.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Anti-hyperglycemic activity of major compounds from <italic>Calea ternifolia</italic></article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>289</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020289</pub-id></element-citation></ref><ref id="B30-molecules-25-04145"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Cecropia obtusifolia</italic> on streptozotocin diabetic rats</article-title><source>J. Ethnopharmacol.</source><year>2001</year><volume>78</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00335-X</pub-id><pub-id pub-id-type="pmid">11694359</pub-id></element-citation></ref><ref id="B31-molecules-25-04145"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revilla-Monsalve</surname><given-names>M.C.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Palomino-Garibay</surname><given-names>M.A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name><name><surname>Islas-Andrade</surname><given-names>S.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Cecropia obtusifolia</italic> Bertol aqueous extracts on type 2 diabetic patients</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>111</volume><fpage>636</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.01.014</pub-id><pub-id pub-id-type="pmid">17291702</pub-id></element-citation></ref><ref id="B32-molecules-25-04145"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Becerra-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>C&#x000e1;rdenas-V&#x000e1;zquez</surname><given-names>R.</given-names></name></person-group><article-title>Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>116</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.10.031</pub-id><pub-id pub-id-type="pmid">18082348</pub-id></element-citation></ref><ref id="B33-molecules-25-04145"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso-Castro</surname><given-names>A.J.</given-names></name><name><surname>Miranda-Torres</surname><given-names>A.C.</given-names></name><name><surname>Gonz&#x000e1;lez-Ch&#x000e1;vez</surname><given-names>M.M.</given-names></name><name><surname>Salazar-Olivo</surname><given-names>L.A.</given-names></name></person-group><article-title><italic>Cecropia obtusifolia</italic> Bertol and its active compound, chlorogenic acid, stimulate 2-NBDglucose uptake in both insulin-sensitive and insulin-resistant 3T3 adipocytes</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>120</volume><fpage>458</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.09.019</pub-id><pub-id pub-id-type="pmid">18948178</pub-id></element-citation></ref><ref id="B34-molecules-25-04145"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Salgado</surname><given-names>J.</given-names></name><name><surname>Ortiz-Andrade</surname><given-names>R.</given-names></name><name><surname>Aguirre-Crespo</surname><given-names>F.</given-names></name><name><surname>Vergara-Galicia</surname><given-names>J.</given-names></name><name><surname>Le&#x000f3;n-Rivera</surname><given-names>I.</given-names></name><name><surname>Montes</surname><given-names>S.</given-names></name><name><surname>Villalobos-Molina</surname><given-names>R.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name></person-group><article-title>Hypoglycemic, vasorelaxant and hepatoprotective effects of <italic>Cochlospermum vitifolium</italic> (Willd.) Sprengel: A potential agent for the treatment of metabolic syndrome</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>109</volume><fpage>400</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.08.008</pub-id><?supplied-pmid 16978815?><pub-id pub-id-type="pmid">16978815</pub-id></element-citation></ref><ref id="B35-molecules-25-04145"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Andrade</surname><given-names>R.</given-names></name><name><surname>Torres-Piedra</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-Salgado</surname><given-names>J.C.</given-names></name><name><surname>Garc&#x000ed;a-Jim&#x000e9;nez</surname><given-names>S.</given-names></name><name><surname>Villalobos-Molina</surname><given-names>R.</given-names></name><name><surname>Ibarra-Barajas</surname><given-names>M.</given-names></name><name><surname>Gallardo-Ortiz</surname><given-names>I.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name></person-group><article-title>Acute and sub-chronic effects of <italic>Cochlospermum vitifolium</italic> in blood glucose levels in normoglycemic and STZ-nicotinamide-induced diabetic rats</article-title><source>Rev. Latinoam. Quim.</source><year>2009</year><volume>37</volume><fpage>122</fpage><lpage>132</lpage></element-citation></ref><ref id="B36-molecules-25-04145"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brindis</surname><given-names>F.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez-Trujano</surname><given-names>M.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name><name><surname>Villalobos-Molina</surname><given-names>R.</given-names></name></person-group><article-title>Postprandial glycaemia and inhibition of &#x003b1;-glucosidase activity by aqueous extract from <italic>Coriandrum sativum</italic></article-title><source>Nat. Prod. Res.</source><year>2014</year><volume>28</volume><fpage>2021</fpage><lpage>2025</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.917414</pub-id><?supplied-pmid 24836119?><pub-id pub-id-type="pmid">24836119</pub-id></element-citation></ref><ref id="B37-molecules-25-04145"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Pati&#x000f1;o</surname><given-names>J.</given-names></name><name><surname>Jim&#x000e9;nez-Balderas</surname><given-names>E.</given-names></name><name><surname>Ju&#x000e1;rez-Oropeza</surname><given-names>M.</given-names></name><name><surname>D&#x00131;az-Zagoya</surname><given-names>J.</given-names></name></person-group><article-title>Hypoglycemic action of <italic>Cucurbita ficifolia</italic> on Type 2 diabetic patients with moderately high blood glucose levels</article-title><source>J. Ethnopharmacol.</source><year>2001</year><volume>77</volume><fpage>99</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00272-0</pub-id><pub-id pub-id-type="pmid">11483384</pub-id></element-citation></ref><ref id="B38-molecules-25-04145"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Hernandez-Galicia</surname><given-names>E.</given-names></name><name><surname>Campos-Sepulveda</surname><given-names>A.E.</given-names></name><name><surname>Xolalpa-Molina</surname><given-names>S.</given-names></name><name><surname>Rivas-Vilchis</surname><given-names>J.F.</given-names></name><name><surname>Vazquez-Carrillo</surname><given-names>L.I.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name></person-group><article-title>Evaluation of the hypoglycemic effect of <italic>Cucurbita ficifolia</italic> Bouch&#x000e9; (Cucurbitaceae) in different experimental models</article-title><source>J. Ethnopharmacol.</source><year>2002</year><volume>82</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00176-9</pub-id><pub-id pub-id-type="pmid">12241994</pub-id></element-citation></ref><ref id="B39-molecules-25-04145"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Flores</surname><given-names>M.</given-names></name><name><surname>Angeles-Mejia</surname><given-names>S.</given-names></name><name><surname>Baiza-Gutman</surname><given-names>L.</given-names></name><name><surname>Medina-Navarro</surname><given-names>R.</given-names></name><name><surname>Hernandez-Saavedra</surname><given-names>D.</given-names></name><name><surname>Ortega-Camarillo</surname><given-names>C.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Cruz</surname><given-names>M.</given-names></name><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name></person-group><article-title>Effect of an aqueous extract of <italic>Cucurbita ficifolia</italic> Bouch&#x000e9; on the glutathione redox cycle in mice with STZ-induced diabetes</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>144</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.08.036</pub-id><pub-id pub-id-type="pmid">22960550</pub-id></element-citation></ref><ref id="B40-molecules-25-04145"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>M.E.M.</given-names></name><name><surname>Ortega-Camarillo</surname><given-names>C.</given-names></name><name><surname>Escobar-Villanueva</surname><given-names>M.D.C.</given-names></name><name><surname>Blancas-Flores</surname><given-names>G.</given-names></name><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Flores-Blancas</surname><given-names>G.</given-names></name></person-group><article-title>Cucurbita ficifolia Bouch&#x000e9; increases insulin secretion in RINm5F cells through an influx of Ca2+ from the endoplasmic reticulum</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>188</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.04.061</pub-id><pub-id pub-id-type="pmid">27174079</pub-id></element-citation></ref><ref id="B41-molecules-25-04145"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessica</surname><given-names>G.G.</given-names></name><name><surname>Mario</surname><given-names>G.L.</given-names></name><name><surname>Alejandro</surname><given-names>Z.</given-names></name><name><surname>Cesar</surname><given-names>A.P.J.</given-names></name><name><surname>Ivan</surname><given-names>J.V.E.</given-names></name><name><surname>Ruben</surname><given-names>R.R.</given-names></name><name><surname>Javier</surname><given-names>A.-A.F.</given-names></name></person-group><article-title>Chemical characterization of a hypoglycemic extract from <italic>Cucurbita ficifolia</italic> bouche that induces liver glycogen accumulation in diabetic mice</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2017</year><volume>14</volume><fpage>218</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.21010/ajtcam.v14i3.24</pub-id><pub-id pub-id-type="pmid">28480434</pub-id></element-citation></ref><ref id="B42-molecules-25-04145"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Amador</surname><given-names>C.P.</given-names></name></person-group><article-title>Flavonol glycosides from <italic>Equisetum myriochaetum</italic></article-title><source>Biochem. Syst. Ecol.</source><year>2000</year><volume>28</volume><fpage>395</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/S0305-1978(99)00074-5</pub-id><pub-id pub-id-type="pmid">10725596</pub-id></element-citation></ref><ref id="B43-molecules-25-04145"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revilla</surname><given-names>M.C.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Islas</surname><given-names>S.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Equisetum myriochaetum</italic> aerial parts on type 2 diabetic patients</article-title><source>J. Ethnopharmacol.</source><year>2002</year><volume>81</volume><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00053-3</pub-id><pub-id pub-id-type="pmid">12020935</pub-id></element-citation></ref><ref id="B44-molecules-25-04145"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetto</surname><given-names>A.A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name><name><surname>Revilla</surname><given-names>M.C.</given-names></name><name><surname>Sergio</surname><given-names>I.A.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Equisetum myriochaetum</italic> aerial parts on streptozotocin diabetic rats</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>72</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00218-X</pub-id><pub-id pub-id-type="pmid">10967463</pub-id></element-citation></ref><ref id="B45-molecules-25-04145"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narv&#x000e1;ez-Mastache</surname><given-names>J.M.</given-names></name><name><surname>Gardu&#x000f1;o-Ram&#x000ed;rez</surname><given-names>M.L.</given-names></name><name><surname>Alvarez</surname><given-names>L.</given-names></name><name><surname>Delgado</surname><given-names>G.</given-names></name></person-group><article-title>Antihyperglycemic Activity and Chemical Constituents of <italic>Eysenhardtia platycarpa</italic></article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1687</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1021/np060166z</pub-id><pub-id pub-id-type="pmid">17190443</pub-id></element-citation></ref><ref id="B46-molecules-25-04145"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narv&#x000e1;ez-Mastache</surname><given-names>J.M.</given-names></name><name><surname>Soto</surname><given-names>C.</given-names></name><name><surname>Delgado</surname><given-names>G.</given-names></name></person-group><article-title>Antioxidant evaluation of eysenhardtia species (fabaceae): Relay synthesis of 3-<italic>O</italic>-acetyl-11&#x003b1;,12&#x003b1;-epoxy-oleanan-28,13&#x003b2;-olide isolated from <italic>E. platycarpa</italic> and Its protective effect in experimental diabetes</article-title><source>Biol. Pharm. Bull.</source><year>2007</year><volume>30</volume><fpage>1503</fpage><lpage>1510</lpage><pub-id pub-id-type="doi">10.1248/bpb.30.1503</pub-id><?supplied-pmid 17666811?><pub-id pub-id-type="pmid">17666811</pub-id></element-citation></ref><ref id="B47-molecules-25-04145"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>R.M.</given-names></name><name><surname>Ocegueda</surname><given-names>A.Z.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>L.J.L.</given-names></name><name><surname>Avila</surname><given-names>A.J.G.</given-names></name><name><surname>Morrow</surname><given-names>W.W.</given-names></name></person-group><article-title>A study of the hypoglucemic effect of some Mexican plants</article-title><source>J. Ethnopharmacol.</source><year>1984</year><volume>12</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(84)90054-0</pub-id><pub-id pub-id-type="pmid">6533411</pub-id></element-citation></ref><ref id="B48-molecules-25-04145"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>G.R.M.</given-names></name><name><surname>Baez</surname><given-names>E.G.</given-names></name></person-group><article-title>Evaluation of antidiabetic, antioxidant and antiglycating activities of the <italic>Eysenhardtia polystachya</italic></article-title><source>Pharmacogn. Mag.</source><year>2014</year><volume>10</volume><fpage>S404</fpage><lpage>S418</lpage><pub-id pub-id-type="doi">10.4103/0973-1296.133295</pub-id><pub-id pub-id-type="pmid">24991120</pub-id></element-citation></ref><ref id="B49-molecules-25-04145"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Guti&#x000e9;rrez</surname><given-names>R.M.</given-names></name><name><surname>Garcia</surname><given-names>C.A.H.</given-names></name><name><surname>Mu&#x000f1;iz-Ram&#x000ed;rez</surname><given-names>A.</given-names></name></person-group><article-title>Properties of flavonoids isolated from the bark of <italic>eysenhardtia polystachya</italic> and their effect on oxidative stress in streptozotocin-induced diabetes mellitus in mice</article-title><source>Oxid. Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><fpage>9156510</fpage><pub-id pub-id-type="doi">10.1155/2016/9156510</pub-id><?supplied-pmid 27668038?><pub-id pub-id-type="pmid">27668038</pub-id></element-citation></ref><ref id="B50-molecules-25-04145"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>G.R.M.</given-names></name><name><surname>Garcia</surname><given-names>C.A.H.</given-names></name><name><surname>Mota</surname><given-names>F.J.M.</given-names></name><name><surname>Grcia</surname><given-names>G.A.H.</given-names></name></person-group><article-title>Dihydrochalcones from the bark of <italic>Eysenhardtia polystachya</italic> inhibits formation of advanced glycation end products at multiple stages in vitro studies</article-title><source>J. Pharm. Pharmacol.</source><year>2017</year><volume>1</volume><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.33697/ajur.2002.016</pub-id></element-citation></ref><ref id="B51-molecules-25-04145"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Guti&#x000e9;rrez</surname><given-names>R.M.</given-names></name><name><surname>Garcia</surname><given-names>C.A.H.</given-names></name><name><surname>Carrera</surname><given-names>S.P.P.</given-names></name><name><surname>Mu&#x000f1;iz-Ram&#x000ed;rez</surname><given-names>A.</given-names></name><name><surname>Flores</surname><given-names>J.M.M.</given-names></name><name><surname>Flores-Valle</surname><given-names>S.O.</given-names></name></person-group><article-title>3&#x02032;-<italic>O</italic>-&#x003b2;-d-glucopyranosyl-&#x003b1;,4,2&#x02032;,4&#x02032;,6&#x02032;-pentahydroxy-dihydrochalcone, from bark of <italic>Eysenhardtia polystachya</italic> prevents diabetic nephropathy via inhibiting protein glycation in STZ-nicotinamide induced diabetic mice</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1214</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24071214</pub-id><?supplied-pmid 30925713?><pub-id pub-id-type="pmid">30925713</pub-id></element-citation></ref><ref id="B52-molecules-25-04145"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-V&#x000e1;squez</surname><given-names>A.</given-names></name><name><surname>Castillejos-Ram&#x000ed;rez</surname><given-names>E.</given-names></name><name><surname>Cristians</surname><given-names>S.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Development of a UHPLC-PDA method for the simultaneous quantification of 4-phenylcoumarins and chlorogenic acid in <italic>Exostema caribaeum</italic> Stem Bark</article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>516</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1021/np400785z</pub-id><pub-id pub-id-type="pmid">24266401</pub-id></element-citation></ref><ref id="B53-molecules-25-04145"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.</given-names></name><name><surname>Garcia-Luna</surname><given-names>V.</given-names></name></person-group><article-title>Hypoglycemic effect of Hamelia patens Jacq., aerial part in STZ-NA-induced diabetic rats</article-title><source>Pharmacologyonline</source><year>2015</year><volume>3</volume><fpage>6569</fpage><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://pharmacologyonline.silae.it/files/archives/2015/vol3/PhOL_2015_3_A010_10_21_Cetto_3_65_69.pdf">https://pharmacologyonline.silae.it/files/archives/2015/vol3/PhOL_2015_3_A010_10_21_Cetto_3_65_69.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B54-molecules-25-04145"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rugerio-Escalona</surname><given-names>C.</given-names></name><name><surname>Ordaz-Pichardo</surname><given-names>C.</given-names></name><name><surname>Becerra-Martinez</surname><given-names>E.</given-names></name><name><surname>Cruz-L&#x000f3;pez</surname><given-names>M.D.C.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>V.E.L.Y.</given-names></name><name><surname>Mendieta</surname><given-names>A.</given-names></name><name><surname>Maldonado-Mendoza</surname><given-names>I.E.</given-names></name><name><surname>Montejo</surname><given-names>F.E.J.</given-names></name></person-group><article-title>&#x0201c;diabetes and metabolism disorders medicinal plants: A glance at the past and a look to the future 2018&#x0201d;: Antihyperglycemic activity of <italic>Hamelia patens</italic> Jacq. extracts</article-title><source>Evid. Based Complementary Altern. Med.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2018/7926452</pub-id></element-citation></ref><ref id="B55-molecules-25-04145"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Analco</surname><given-names>J.</given-names></name><name><surname>Medina-Campos</surname><given-names>O.</given-names></name><name><surname>Brindis</surname><given-names>F.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antidiabetic properties of selected Mexican copalchis of the Rubiaceae family</article-title><source>Phytochemistry</source><year>2007</year><volume>68</volume><fpage>2087</fpage><lpage>2095</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2007.05.006</pub-id><?supplied-pmid 17575991?><pub-id pub-id-type="pmid">17575991</pub-id></element-citation></ref><ref id="B56-molecules-25-04145"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristians</surname><given-names>S.</given-names></name><name><surname>Guerrero-Analco</surname><given-names>J.A.</given-names></name><name><surname>P&#x000e9;rez-V&#x000e1;squez</surname><given-names>A.</given-names></name><name><surname>Palacios-Espinosa</surname><given-names>F.</given-names></name><name><surname>Ciangherotti</surname><given-names>C.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycemic activity of extracts and compounds from the leaves of <italic>Hintonia standleyana</italic> and <italic>H. latiflora</italic>: Potential alternatives to the use of the stem bark of these species (1)</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>408</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1021/np800642d</pub-id><?supplied-pmid 19140696?><pub-id pub-id-type="pmid">19140696</pub-id></element-citation></ref><ref id="B57-molecules-25-04145"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Ch&#x000e1;vez</surname><given-names>J.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M.D.C.</given-names></name><name><surname>Glenn</surname><given-names>A.E.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Thielavins A, J and K: &#x003b1;-Glucosidase inhibitors from MEXU 27095, an endophytic fungus from <italic>Hintonia latiflora</italic></article-title><source>Phytochemistry</source><year>2013</year><volume>94</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.05.021</pub-id><pub-id pub-id-type="pmid">23809634</pub-id></element-citation></ref><ref id="B58-molecules-25-04145"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristians</surname><given-names>S.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name></person-group><article-title>Phenological and geographical influence in the concentration of selected bioactive 4-phenylcoumarins and chlorogenic acid in <italic>Hintonia latiflora</italic> leaves</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>152</volume><fpage>308</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.12.054</pub-id><pub-id pub-id-type="pmid">24412552</pub-id></element-citation></ref><ref id="B59-molecules-25-04145"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Analco</surname><given-names>J.A.</given-names></name><name><surname>Hersch-MartInez</surname><given-names>P.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antihyperglycemic effect of constituents from <italic>Hintonia standleyana</italic> in streptozotocin-induced diabetic rats</article-title><source>Planta Med.</source><year>2005</year><volume>71</volume><fpage>1099</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1055/s-2005-873137</pub-id><pub-id pub-id-type="pmid">16395644</pub-id></element-citation></ref><ref id="B60-molecules-25-04145"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Campos-Sepulveda</surname><given-names>A.</given-names></name><name><surname>Xolalpa-Molina</surname><given-names>S.</given-names></name><name><surname>Hernandez-Galicia</surname><given-names>E.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycaemic activity of <italic>Ibervillea sonorae</italic> roots in healthy and diabetic mice and rats</article-title><source>Pharm. Biol.</source><year>2002</year><volume>40</volume><fpage>570</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1076/phbi.40.8.570.14652</pub-id></element-citation></ref><ref id="B61-molecules-25-04145"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Calzada-Bermejo</surname><given-names>F.</given-names></name><name><surname>Hernandez-Galicia</surname><given-names>E.</given-names></name><name><surname>Ruiz-Angeles</surname><given-names>C.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name></person-group><article-title>Acute and chronic hypoglycemic effect of <italic>Ibervillea sonorae</italic> root extracts-II</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>97</volume><fpage>447</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.11.035</pub-id><pub-id pub-id-type="pmid">15740879</pub-id></element-citation></ref><ref id="B62-molecules-25-04145"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Galicia</surname><given-names>E.</given-names></name><name><surname>Calzada</surname><given-names>F.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Alarc&#x000f3;n-Aguilar</surname><given-names>F.</given-names></name></person-group><article-title>Monoglycerides and fatty acids from <italic>Ibervillea sonorae</italic> root: Isolation and hypoglycemic activity</article-title><source>Planta Med.</source><year>2007</year><volume>73</volume><fpage>236</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1055/s-2007-967117</pub-id><?supplied-pmid 17318782?><pub-id pub-id-type="pmid">17318782</pub-id></element-citation></ref><ref id="B63-molecules-25-04145"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Ram&#x000ed;rez</surname><given-names>F.</given-names></name><name><surname>Escalona-Cardoso</surname><given-names>G.N.</given-names></name><name><surname>Gardu&#x000f1;o-Siciliano</surname><given-names>L.</given-names></name><name><surname>Galaviz-Hern&#x000e1;ndez</surname><given-names>C.</given-names></name><name><surname>Paniagua-Castro</surname><given-names>N.</given-names></name></person-group><article-title>Antiobesity and hypoglycaemic effects of aqueous extract of <italic>Ibervillea sonorae</italic> in mice fed a high-fat diet with fructose</article-title><source>J. Biomed. Biotechnol.</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2011/968984</pub-id><?supplied-pmid 22174560?><pub-id pub-id-type="pmid">22174560</pub-id></element-citation></ref><ref id="B64-molecules-25-04145"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapata-Bustos</surname><given-names>R.</given-names></name><name><surname>Alonso-Castro</surname><given-names>A.J.</given-names></name><name><surname>Gomez-Sanchez</surname><given-names>M.</given-names></name><name><surname>Salazar-Olivo</surname><given-names>L.A.</given-names></name></person-group><article-title><italic>Ibervillea sonorae</italic> (Cucurbitaceae) induces the glucose uptake in human adipocytes by activating a PI3K-independent pathway</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>152</volume><fpage>546</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.01.041</pub-id><?supplied-pmid 24534528?><pub-id pub-id-type="pmid">24534528</pub-id></element-citation></ref><ref id="B65-molecules-25-04145"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas-Ramirez</surname><given-names>D.</given-names></name><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Pereda-Miranda</surname><given-names>R.</given-names></name></person-group><article-title>Morning glory resin glycosides as &#x003b1;-glucosidase inhibitors: In vitro and in silico analysis</article-title><source>Phytochemistry</source><year>2018</year><volume>148</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2018.01.012</pub-id><?supplied-pmid 29421509?><pub-id pub-id-type="pmid">29421509</pub-id></element-citation></ref><ref id="B66-molecules-25-04145"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Andrade</surname><given-names>R.</given-names></name><name><surname>Caba&#x000f1;as-Wuan</surname><given-names>A.</given-names></name><name><surname>Arana-Arg&#x000e1;ez</surname><given-names>V.E.</given-names></name><name><surname>Alonso-Castro</surname><given-names>A.J.</given-names></name><name><surname>Zapata-Bustos</surname><given-names>R.</given-names></name><name><surname>Salazar-Olivo</surname><given-names>L.A.</given-names></name><name><surname>Dom&#x000ed;nguez</surname><given-names>F.</given-names></name><name><surname>Ch&#x000e1;vez</surname><given-names>M.</given-names></name><name><surname>Carranza-&#x000c1;lvarez</surname><given-names>C.</given-names></name><name><surname>Garc&#x000ed;a-Carranc&#x000e1;</surname><given-names>A.</given-names></name></person-group><article-title>Antidiabetic effects of <italic>Justicia spicigera</italic> Schltdl (Acanthaceae)</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>143</volume><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.06.043</pub-id><pub-id pub-id-type="pmid">22819688</pub-id></element-citation></ref><ref id="B67-molecules-25-04145"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brindis</surname><given-names>F.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>R.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name><name><surname>Rodr&#x00131;guez</surname><given-names>R.</given-names></name></person-group><article-title>(Z)-3-Butylidenephthalide from <italic>Ligusticum porteri</italic>, an &#x003b1;-glucosidase Inhibitor</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1021/np100447a</pub-id><pub-id pub-id-type="pmid">20879744</pub-id></element-citation></ref><ref id="B68-molecules-25-04145"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Bocanegra</surname><given-names>L.</given-names></name><name><surname>Torres-Col&#x000ed;n</surname><given-names>R.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Calder&#x000f3;n</surname><given-names>J.S.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>In vivo and in vitro &#x003b1;-glucosidase inhibitory activity of perfoliatin a from <italic>Melampodium Perfoliatum</italic></article-title><source>Nat. Prod. Commun.</source><year>2019</year><volume>14</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1177/1934578X1901400102</pub-id></element-citation></ref><ref id="B69-molecules-25-04145"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Mart&#x000ed;nez-Zurita</surname><given-names>E.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Malmea depressa</italic> root on streptozotocin diabetic rats</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>100</volume><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.03.021</pub-id><pub-id pub-id-type="pmid">15990260</pub-id></element-citation></ref><ref id="B70-molecules-25-04145"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Mart&#x000ed;nez-Zurita</surname><given-names>E.</given-names></name><name><surname>Soto-Constantino</surname><given-names>A.</given-names></name><name><surname>Revilla-Monsalve</surname><given-names>C.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Chronic hypoglycemic effect of <italic>Malmea depressa</italic> root on n5-streptozotocin diabetic rats</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>116</volume><fpage>358</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.11.043</pub-id><pub-id pub-id-type="pmid">18242024</pub-id></element-citation></ref><ref id="B71-molecules-25-04145"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Inhibition of gluconeogenesis by <italic>Malmea depressa</italic> root</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>137</volume><fpage>930</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.06.028</pub-id><pub-id pub-id-type="pmid">21756989</pub-id></element-citation></ref><ref id="B72-molecules-25-04145"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Anti-hyperglycemic effect of <italic>Opuntia streptacantha</italic> Lem</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>133</volume><fpage>940</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.11.022</pub-id><pub-id pub-id-type="pmid">21111796</pub-id></element-citation></ref><ref id="B73-molecules-25-04145"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becerra-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Effect of <italic>Opuntia streptacantha</italic> Lem. on alpha-glucosidase activity</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>139</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.11.039</pub-id><?supplied-pmid 22155472?><pub-id pub-id-type="pmid">22155472</pub-id></element-citation></ref><ref id="B74-molecules-25-04145"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Jim&#x000e9;nez-Estrada</surname><given-names>M.</given-names></name><name><surname>Reyes-Chilpa</surname><given-names>R.</given-names></name><name><surname>Gonzalez-Paredes</surname><given-names>B.</given-names></name><name><surname>Flores-Saenz</surname><given-names>J.</given-names></name></person-group><article-title>Effects of three Mexican medicinal plants (Asteraceae) on blood glucose levels in healthy mice and rabbits</article-title><source>J. Ethnopharmacol.</source><year>1997</year><volume>55</volume><fpage>171</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(96)01494-8</pub-id><pub-id pub-id-type="pmid">9080337</pub-id></element-citation></ref><ref id="B75-molecules-25-04145"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name><name><surname>Jim&#x000e9;nez-Estrada</surname><given-names>M.</given-names></name><name><surname>Reyes-Chilpa</surname><given-names>R.</given-names></name><name><surname>Gonzalez-Paredes</surname><given-names>B.</given-names></name><name><surname>Contreras-Weber</surname><given-names>C.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycemic activity of root water decoction, sesquiterpenoids, and one polysaccharide fraction from <italic>Psacalium decompositum</italic> in mice</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>69</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(99)00039-2</pub-id><pub-id pub-id-type="pmid">10722202</pub-id></element-citation></ref><ref id="B76-molecules-25-04145"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrada</surname><given-names>M.J.</given-names></name><name><surname>Merino-Aguilar</surname><given-names>H.</given-names></name><name><surname>Lopez-Fernandez</surname><given-names>A.</given-names></name><name><surname>Rojano-Vilchis</surname><given-names>N.A.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name></person-group><article-title>Chemical characterization and evaluation of the hypoglycemic effect of fructooligosaccharides from <italic>Psacalium decompositum</italic></article-title><source>J. Complement. Integr. Med.</source><year>2011</year><volume>8</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.2202/1553-3840.1413</pub-id></element-citation></ref><ref id="B77-molecules-25-04145"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino-Aguilar</surname><given-names>H.</given-names></name><name><surname>Arrieta-Baez</surname><given-names>D.</given-names></name><name><surname>Estrada</surname><given-names>M.J.</given-names></name><name><surname>Magos-Guerrero</surname><given-names>G.</given-names></name><name><surname>Hern&#x000e1;ndez-Bautista</surname><given-names>R.J.</given-names></name><name><surname>Susunaga-Notario</surname><given-names>A.D.C.</given-names></name><name><surname>Almanza-P&#x000e9;rez</surname><given-names>J.C.</given-names></name><name><surname>Blancas-Flores</surname><given-names>G.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Alarcon-Aguilar</surname><given-names>F.</given-names></name></person-group><article-title>Effect of fructooligosaccharides fraction from <italic>Psacalium decompositum</italic> on inflammation and dyslipidemia in rats with fructose-induced obesity</article-title><source>Nutrients</source><year>2014</year><volume>6</volume><fpage>591</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.3390/nu6020591</pub-id><pub-id pub-id-type="pmid">24481132</pub-id></element-citation></ref><ref id="B78-molecules-25-04145"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rodr&#x000ed;guez</surname><given-names>D.J.</given-names></name><name><surname>Garc&#x000ed;a-Hern&#x000e1;ndez</surname><given-names>L.</given-names></name><name><surname>Rocha-Guzm&#x000e1;n</surname><given-names>N.E.</given-names></name><name><surname>Moreno-Jim&#x000e9;nez</surname><given-names>M.</given-names></name><name><surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname><given-names>R.</given-names></name><name><surname>D&#x000ed;az-Jim&#x000e9;nez</surname><given-names>M.</given-names></name><name><surname>Flores-L&#x000f3;pez</surname><given-names>M.L.</given-names></name><name><surname>Villarreal-Quintanilla</surname><given-names>J.</given-names></name><name><surname>Pe&#x000f1;a-Ramos</surname><given-names>F.</given-names></name><name><surname>Carrillo-Lomel&#x000ed;</surname><given-names>D.</given-names></name></person-group><article-title>Hypoglycemic and anti-inflammatory effects of <italic>Psacalium paucicapitatum</italic> corms infusions</article-title><source>Ind. Crop. Prod.</source><year>2017</year><volume>107</volume><fpage>482</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2017.04.022</pub-id></element-citation></ref><ref id="B79-molecules-25-04145"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-Espinosa</surname><given-names>J.J.</given-names></name><name><surname>Rios</surname><given-names>M.Y.</given-names></name><name><surname>Martinez</surname><given-names>S.L.</given-names></name><name><surname>L&#x000f3;pez-Vallejo</surname><given-names>F.</given-names></name><name><surname>Medina-Franco</surname><given-names>J.L.</given-names></name><name><surname>Paoli</surname><given-names>P.</given-names></name><name><surname>Camici</surname><given-names>G.</given-names></name><name><surname>Navarrete-V&#x000e1;zquez</surname><given-names>G.</given-names></name><name><surname>Ortiz-Andrade</surname><given-names>R.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name></person-group><article-title>Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP&#x02013;1B: In vitro, in silico, and in vivo approaches</article-title><source>Eur. J. Med. Chem.</source><year>2011</year><volume>46</volume><fpage>2243</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2011.03.005</pub-id><pub-id pub-id-type="pmid">21453996</pub-id></element-citation></ref><ref id="B80-molecules-25-04145"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Martinez</surname><given-names>S.</given-names></name><name><surname>Navarrete-V&#x000e1;zquez</surname><given-names>G.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name><name><surname>Leon</surname><given-names>I.</given-names></name><name><surname>Rios</surname><given-names>M.Y.</given-names></name></person-group><article-title>Chemical constituents of the hemiparasitic plant <italic>Phoradendron brachystachyum</italic> DC Nutt (Viscaceae)</article-title><source>Nat. Prod. Res.</source><year>2013</year><volume>27</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1080/14786419.2012.662646</pub-id><pub-id pub-id-type="pmid">22360797</pub-id></element-citation></ref><ref id="B81-molecules-25-04145"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-Espinosa</surname><given-names>J.J.</given-names></name><name><surname>Garc&#x000ed;a-Jimenez</surname><given-names>S.</given-names></name><name><surname>Rios</surname><given-names>M.Y.</given-names></name><name><surname>Medina-Franco</surname><given-names>J.L.</given-names></name><name><surname>L&#x000f3;pez-Vallejo</surname><given-names>F.</given-names></name><name><surname>Webster</surname><given-names>S.P.</given-names></name><name><surname>Binnie</surname><given-names>M.</given-names></name><name><surname>Ibarra-Barajas</surname><given-names>M.</given-names></name><name><surname>Ortiz-Andrade</surname><given-names>R.</given-names></name><name><surname>Estrada-Soto</surname><given-names>S.</given-names></name></person-group><article-title>Antihyperglycemic and sub-chronic antidiabetic actions of morolic and moronic acids, in vitro and in silico inhibition of 11&#x003b2;-HSD 1</article-title><source>Phytomedicine</source><year>2013</year><volume>20</volume><fpage>571</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.01.013</pub-id><?supplied-pmid 23453304?><pub-id pub-id-type="pmid">23453304</pub-id></element-citation></ref><ref id="B82-molecules-25-04145"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Mares</surname><given-names>M.L.R.</given-names></name></person-group><article-title>Hypoglycemic effect of the <italic>Rhizophora mangle</italic> cortex on STZ-NA-induced diabetic rats</article-title><source>Pharmacologyonline</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>5</lpage><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://pharmacologyonline.silae.it/files/archives/2012/vol3/PhOL_2012_3_A001_004_Cetto.pdf">https://pharmacologyonline.silae.it/files/archives/2012/vol3/PhOL_2012_3_A001_004_Cetto.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B83-molecules-25-04145"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Torres-Valle</surname><given-names>G.M.</given-names></name><name><surname>Quijano</surname><given-names>L.</given-names></name></person-group><article-title>Phytochemical composition and chronic hypoglycemic effect of <italic>Rhizophora mangle</italic> cortex on STZ-NA-induced diabetic rats</article-title><source>Rev. Bras. Farm.</source><year>2017</year><volume>27</volume><fpage>744</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2017.09.007</pub-id></element-citation></ref><ref id="B84-molecules-25-04145"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Cabello-Hern&#x000e1;ndez</surname><given-names>C.A.</given-names></name><name><surname>C&#x000e1;rdenas-V&#x000e1;zquez</surname><given-names>R.</given-names></name></person-group><article-title>Alpha-glucosidase inhibiting activity of five Mexican plants used in the treatment of type 2 diabetes</article-title><source>Pharmacologyonline</source><year>2015</year><volume>1</volume><fpage>67</fpage><lpage>71</lpage><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://pharmacologyonline.silae.it">https://pharmacologyonline.silae.it</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B85-molecules-25-04145"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Bocanegra</surname><given-names>L.</given-names></name><name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>&#x003b1;-Glucosidase Inhibitors from <italic>Salvia circinata</italic></article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1584</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00155</pub-id><pub-id pub-id-type="pmid">28422509</pub-id></element-citation></ref><ref id="B86-molecules-25-04145"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaro</surname><given-names>C.A.B.</given-names></name><name><surname>Gonz&#x000e1;lez-Cortazar</surname><given-names>M.</given-names></name><name><surname>Herrera-Ruiz</surname><given-names>M.</given-names></name><name><surname>Roman-Ramos</surname><given-names>R.</given-names></name><name><surname>Aguilar-Santamar&#x000ed;a</surname><given-names>L.</given-names></name><name><surname>Tortoriello-Garc&#x00131;a</surname><given-names>J.</given-names></name><name><surname>Jimenez-Ferrer</surname><given-names>I.</given-names></name></person-group><article-title>Hypoglycemic and hypotensive activity of a root extract <italic>of Smilax aristolochiifolia</italic>, standardized on N-trans-feruloyl-tyramine</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>11366</fpage><lpage>11384</lpage><pub-id pub-id-type="doi">10.3390/molecules190811366</pub-id><pub-id pub-id-type="pmid">25090124</pub-id></element-citation></ref><ref id="B87-molecules-25-04145"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-N&#x000e1;jera</surname><given-names>V.C.</given-names></name><name><surname>Guti&#x000e9;rrez-Uribe</surname><given-names>J.A.</given-names></name><name><surname>Antunes-Ricardo</surname><given-names>M.</given-names></name><name><surname>Hidalgo-Figueroa</surname><given-names>S.</given-names></name><name><surname>Del-Toro-S&#x000e1;nchez</surname><given-names>C.L.</given-names></name><name><surname>Salazar-Olivo</surname><given-names>L.A.</given-names></name><name><surname>Cervantes</surname><given-names>E.L.</given-names></name></person-group><article-title><italic>Smilax aristolochiifolia</italic> root extract and its compounds chlorogenic acid and astilbin inhibit the activity of &#x003b1;-amylase and &#x003b1;-glucosidase enzymes</article-title><source>Evid. Based Complementary Altern. Med.</source><year>2018</year><volume>2018</volume><fpage>6247306</fpage><pub-id pub-id-type="doi">10.1155/2018/6247306</pub-id></element-citation></ref><ref id="B88-molecules-25-04145"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Hypoglycemic effect of Smilax moranensis root on N5-STZ diabetic rats</article-title><source>Pharmacologyonline</source><year>2011</year><volume>1</volume><fpage>111</fpage><lpage>115</lpage><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://pharmacologyonline.silae.it/files/newsletter/2011/vol1/013.cettorev.pdf">https://pharmacologyonline.silae.it/files/newsletter/2011/vol1/013.cettorev.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-06-10">(accessed on 10 June 2020)</date-in-citation></element-citation></ref><ref id="B89-molecules-25-04145"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romo-P&#x000e9;rez</surname><given-names>A.</given-names></name><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name></person-group><article-title>Chronic hypoglycemic effect and phytochemical composition of <italic>Smilax moranensis</italic> roots</article-title><source>Rev. Bras. Farm.</source><year>2019</year><volume>29</volume><fpage>246</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2019.02.007</pub-id></element-citation></ref><ref id="B90-molecules-25-04145"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovalle-Magallanes</surname><given-names>B.</given-names></name><name><surname>Medina-Campos</surname><given-names>O.N.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Hypoglycemic and antihyperglycemic effects of phytopreparations and limonoids from <italic>Swietenia humilis</italic></article-title><source>Phytochemistry</source><year>2015</year><volume>110</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2014.11.004</pub-id><pub-id pub-id-type="pmid">25534951</pub-id></element-citation></ref><ref id="B91-molecules-25-04145"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovalle-Magallanes</surname><given-names>B.</given-names></name><name><surname>D&#x000e9;ciga-Campos</surname><given-names>M.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antihyperalgesic activity of a mexicanolide isolated from <italic>Swietenia humilis</italic> extract in nicotinamide-streptozotocin hyperglycemic mice</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>92</volume><fpage>324</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.05.073</pub-id><pub-id pub-id-type="pmid">28551554</pub-id></element-citation></ref><ref id="B92-molecules-25-04145"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovalle-Magallanes</surname><given-names>B.</given-names></name><name><surname>Navarrete</surname><given-names>A.</given-names></name><name><surname>Haddad</surname><given-names>P.S.</given-names></name><name><surname>Tovar</surname><given-names>A.R.</given-names></name><name><surname>Noriega</surname><given-names>L.G.</given-names></name><name><surname>Tovar-Palacio</surname><given-names>C.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Multi-target antidiabetic mechanisms of mexicanolides from <italic>Swietenia humilis</italic></article-title><source>Phytomedicine</source><year>2019</year><volume>58</volume><fpage>152891</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2019.152891</pub-id><pub-id pub-id-type="pmid">30901665</pub-id></element-citation></ref><ref id="B93-molecules-25-04145"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Santamar&#x000ed;a</surname><given-names>L.</given-names></name><name><surname>Ramirez</surname><given-names>G.</given-names></name><name><surname>Nicasio</surname><given-names>P.</given-names></name><name><surname>Alegr&#x000ed;a-Reyes</surname><given-names>C.</given-names></name><name><surname>Herrera-Arellano</surname><given-names>A.</given-names></name></person-group><article-title>Antidiabetic activities of <italic>Tecoma stans</italic> (L.) Juss. ex Kunth</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>124</volume><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.04.033</pub-id><?supplied-pmid 19397980?><pub-id pub-id-type="pmid">19397980</pub-id></element-citation></ref><ref id="B94-molecules-25-04145"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>G.</given-names></name><name><surname>Zamilpa</surname><given-names>A.</given-names></name><name><surname>Zavala</surname><given-names>M.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>Morales</surname><given-names>D.</given-names></name><name><surname>Tortoriello-Garc&#x00131;a</surname><given-names>J.</given-names></name><name><surname>Guillermo</surname><given-names>R.</given-names></name><name><surname>Alejandro</surname><given-names>Z.</given-names></name><name><surname>Miguel</surname><given-names>Z.</given-names></name><name><surname>Julia</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Chrysoeriol and other polyphenols from <italic>Tecoma stans</italic> with lipase inhibitory activity</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>185</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.03.014</pub-id><?supplied-pmid 26970570?><pub-id pub-id-type="pmid">26970570</pub-id></element-citation></ref><ref id="B95-molecules-25-04145"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra-Naranjo</surname><given-names>A.</given-names></name><name><surname>Delgado-Montemayor</surname><given-names>C.</given-names></name><name><surname>Fraga-L&#x000f3;pez</surname><given-names>A.</given-names></name><name><surname>Casta&#x000f1;eda-Corral</surname><given-names>G.</given-names></name><name><surname>Salazar-Aranda</surname><given-names>R.</given-names></name><name><surname>Acevedo-Fern&#x000e1;ndez</surname><given-names>J.J.</given-names></name><name><surname>De Torres</surname><given-names>N.W.</given-names></name></person-group><article-title>Acute hypoglycemic and antidiabetic effect of teuhetenone a isolated from <italic>Turnera diffusa</italic></article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>599</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22040599</pub-id></element-citation></ref><ref id="B96-molecules-25-04145"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semaming</surname><given-names>Y.</given-names></name><name><surname>Kukongviriyapan</surname><given-names>U.</given-names></name><name><surname>Kongyingyoes</surname><given-names>B.</given-names></name><name><surname>Thukhammee</surname><given-names>W.</given-names></name><name><surname>Pannangpetch</surname><given-names>P.</given-names></name></person-group><article-title>Protocatechuic acid restores vascular responses in rats with chronic diabetes induced by streptozotocin</article-title><source>Phytother. Res.</source><year>2015</year><volume>30</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1002/ptr.5520</pub-id><pub-id pub-id-type="pmid">26575211</pub-id></element-citation></ref><ref id="B97-molecules-25-04145"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scazzocchio</surname><given-names>B.</given-names></name><name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name><name><surname>Filesi</surname><given-names>C.</given-names></name><name><surname>D&#x02019;Archivio</surname><given-names>M.</given-names></name><name><surname>Santangelo</surname><given-names>C.</given-names></name><name><surname>Giovannini</surname><given-names>C.</given-names></name><name><surname>Iacovelli</surname><given-names>A.</given-names></name><name><surname>Silecchia</surname><given-names>G.</given-names></name><name><surname>Volti</surname><given-names>G.L.</given-names></name><name><surname>Galvano</surname><given-names>F.</given-names></name></person-group><article-title>Cyanidin-3-<italic>O</italic>-&#x003b2;-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPAR&#x003b3; activity in human omental adipocytes</article-title><source>Diabetes</source><year>2011</year><volume>60</volume><fpage>2234</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.2337/db10-1461</pub-id><?supplied-pmid 21788573?><pub-id pub-id-type="pmid">21788573</pub-id></element-citation></ref><ref id="B98-molecules-25-04145"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.-L.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>S.-Y.</given-names></name><name><surname>Meng</surname><given-names>X.-M.</given-names></name><name><surname>Ma</surname><given-names>W.-F.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group><article-title>The mechanism of interactions between flavan-3-ols against a-glucosidase and their in vivo antihyperglycemic effects</article-title><source>Bioorganic Chem.</source><year>2019</year><volume>85</volume><fpage>364</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2018.12.037</pub-id></element-citation></ref><ref id="B99-molecules-25-04145"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitchai</surname><given-names>D.</given-names></name><name><surname>Balasubramanian</surname><given-names>K.</given-names></name><name><surname>Rajalakshmi</surname><given-names>M.</given-names></name><name><surname>Eliza</surname><given-names>J.</given-names></name><name><surname>Selvaraj</surname><given-names>J.</given-names></name></person-group><article-title>Insulin mimetic impact of catechin isolated from <italic>Cassia fistula</italic> on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.10.018</pub-id><pub-id pub-id-type="pmid">19931438</pub-id></element-citation></ref><ref id="B100-molecules-25-04145"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amalan</surname><given-names>V.</given-names></name><name><surname>Vijayakumar</surname><given-names>N.</given-names></name><name><surname>Indumathi</surname><given-names>D.</given-names></name><name><surname>Ramakrishnan</surname><given-names>A.</given-names></name></person-group><article-title>Antidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: In vivo approach</article-title><source>Biomed. Pharmacother.</source><year>2016</year><volume>84</volume><fpage>230</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.039</pub-id><pub-id pub-id-type="pmid">27662473</pub-id></element-citation></ref><ref id="B101-molecules-25-04145"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matin</surname><given-names>A.</given-names></name><name><surname>Doddareddy</surname><given-names>M.R.</given-names></name><name><surname>Gavande</surname><given-names>N.</given-names></name><name><surname>Nammi</surname><given-names>S.</given-names></name><name><surname>Groundwater</surname><given-names>P.W.</given-names></name><name><surname>Roubin</surname><given-names>R.H.</given-names></name><name><surname>Hibbs</surname><given-names>D.E.</given-names></name></person-group><article-title>The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists</article-title><source>Bioorg. Med. Chem.</source><year>2013</year><volume>21</volume><fpage>766</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2012.11.040</pub-id><pub-id pub-id-type="pmid">23265844</pub-id></element-citation></ref><ref id="B102-molecules-25-04145"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y.-J.</given-names></name><name><surname>Jung</surname><given-names>U.J.</given-names></name><name><surname>Lee</surname><given-names>M.-K.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Jeon</surname><given-names>S.-M.</given-names></name><name><surname>Park</surname><given-names>Y.B.</given-names></name><name><surname>Chung</surname><given-names>H.-G.</given-names></name><name><surname>Baek</surname><given-names>N.-I.</given-names></name><name><surname>Lee</surname><given-names>K.-T.</given-names></name><name><surname>Jeong</surname><given-names>T.-S.</given-names></name><etal/></person-group><article-title>Eupatilin, isolated from <italic>Artemisia princeps</italic> Pampanini, enhances hepatic glucose metabolism and pancreatic &#x003b2;-cell function in type 2 diabetic mice</article-title><source>Diabetes Res. Clin. Pract.</source><year>2008</year><volume>82</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2008.06.012</pub-id><pub-id pub-id-type="pmid">18703253</pub-id></element-citation></ref><ref id="B103-molecules-25-04145"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y.-J.</given-names></name><name><surname>Jung</surname><given-names>U.-J.</given-names></name><name><surname>Jeon</surname><given-names>S.-M.</given-names></name><name><surname>Yeo</surname><given-names>J.-Y.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>D.-J.</given-names></name><name><surname>Lee</surname><given-names>M.-K.</given-names></name><name><surname>Baek</surname><given-names>N.-I.</given-names></name><name><surname>Chung</surname><given-names>H.-G.</given-names></name><name><surname>Choi</surname><given-names>M.-S.</given-names></name></person-group><article-title>Antihyperglycemic and antioxidant properties of jaceosidin, a flavonoid isolated from <italic>Artemisia Princeps</italic>, in type 2 diabetic mice</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><fpage>pA667</fpage></element-citation></ref><ref id="B104-molecules-25-04145"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Mangelinckx</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>De Kimpe</surname><given-names>N.</given-names></name></person-group><article-title>Caffeoylquinic acid derivatives isolated from the aerial parts of <italic>Gynura divaricata</italic> and their yeast &#x003b1;-glucosidase and PTP1B inhibitory activity</article-title><source>Fitoterapia</source><year>2014</year><volume>99</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2014.08.015</pub-id><?supplied-pmid 25172103?><pub-id pub-id-type="pmid">25172103</pub-id></element-citation></ref><ref id="B105-molecules-25-04145"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somsak</surname><given-names>N.</given-names></name><name><surname>Peerawit</surname><given-names>P.</given-names></name><name><surname>Chusri</surname><given-names>T.</given-names></name></person-group><article-title>Hypoglycemic activity in diabetic rats of stigmasterol and sitosterol-3-<italic>O-</italic>&#x003b2;-<sc>d</sc>-glucopyranoside isolated from <italic>Pseuderanthemum palatiferum</italic> (Nees) Radlk. leaf extract</article-title><source>J. Med. Plants Res.</source><year>2015</year><volume>9</volume><fpage>629</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.5897/JMPR2014.5722</pub-id></element-citation></ref><ref id="B106-molecules-25-04145"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>R.</given-names></name><name><surname>Varshney</surname><given-names>R.</given-names></name><name><surname>Mishra</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Sircar</surname><given-names>D.</given-names></name><name><surname>Roy</surname><given-names>P.</given-names></name></person-group><article-title>Kaempferol alleviates palmitic acid-induced lipid stores, endoplasmic reticulum stress and pancreatic &#x003b2;-cell dysfunction through AMPK/mTOR-mediated lipophagy</article-title><source>J. Nutr. Biochem.</source><year>2018</year><volume>57</volume><fpage>212</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2018.02.017</pub-id><pub-id pub-id-type="pmid">29758481</pub-id></element-citation></ref><ref id="B107-molecules-25-04145"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Gong</surname><given-names>D.</given-names></name></person-group><article-title>Inhibitory kinetics and mechanism of kaempferol on &#x003b1;-glucosidase</article-title><source>Food Chem.</source><year>2016</year><volume>190</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.05.088</pub-id><pub-id pub-id-type="pmid">26212963</pub-id></element-citation></ref><ref id="B108-molecules-25-04145"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Yamashita</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>A.</given-names></name><name><surname>Croft</surname><given-names>K.D.</given-names></name><name><surname>Ashida</surname><given-names>H.</given-names></name></person-group><article-title>Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>2690</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-38711-7</pub-id><pub-id pub-id-type="pmid">30804434</pub-id></element-citation></ref><ref id="B109-molecules-25-04145"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Tsao</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name></person-group><article-title>Screening and structural characterization of &#x003b1;-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MS n and SORI-CID FTICR MS</article-title><source>J. Am. Soc. Mass Spectrom.</source><year>2009</year><volume>20</volume><fpage>1496</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1016/j.jasms.2009.04.003</pub-id><pub-id pub-id-type="pmid">19443236</pub-id></element-citation></ref><ref id="B110-molecules-25-04145"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roghani</surname><given-names>M.</given-names></name><name><surname>Fallahi</surname><given-names>F.</given-names></name><name><surname>Moghadami</surname><given-names>S.</given-names></name></person-group><article-title>Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats</article-title><source>Indian J. Pharmacol.</source><year>2012</year><volume>44</volume><fpage>382</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.4103/0253-7613.96350</pub-id><pub-id pub-id-type="pmid">22701251</pub-id></element-citation></ref><ref id="B111-molecules-25-04145"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>F.S.G.</given-names></name><name><surname>Oliveira</surname><given-names>P.J.</given-names></name><name><surname>Duarte</surname><given-names>M.</given-names></name></person-group><article-title>Oleanolic, ursolic, and betulinic acids as food supplements or pharmaceutical agents for type 2 diabetes: Promise or illusion?</article-title><source>J. Agric. Food Chem.</source><year>2016</year><volume>64</volume><fpage>2991</fpage><lpage>3008</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.5b06021</pub-id><pub-id pub-id-type="pmid">27012451</pub-id></element-citation></ref><ref id="B112-molecules-25-04145"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>U.J.</given-names></name><name><surname>Lee</surname><given-names>M.-K.</given-names></name><name><surname>Park</surname><given-names>Y.B.</given-names></name><name><surname>Jeon</surname><given-names>S.-M.</given-names></name><name><surname>Choi</surname><given-names>M.-S.</given-names></name></person-group><article-title>Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2006</year><volume>318</volume><fpage>476</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1124/jpet.106.105163</pub-id><pub-id pub-id-type="pmid">16644902</pub-id></element-citation></ref><ref id="B113-molecules-25-04145"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cremonini</surname><given-names>E.</given-names></name><name><surname>Bettaieb</surname><given-names>A.</given-names></name><name><surname>Haj</surname><given-names>F.G.</given-names></name><name><surname>Fraga</surname><given-names>C.G.</given-names></name><name><surname>Oteiza</surname><given-names>P.</given-names></name></person-group><article-title>(-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice</article-title><source>Arch. Biochem. Biophys.</source><year>2016</year><volume>599</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2016.03.006</pub-id><?supplied-pmid 26968772?><pub-id pub-id-type="pmid">26968772</pub-id></element-citation></ref><ref id="B114-molecules-25-04145"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>M.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of rat small intestinal sucrase and&#x003b1;-glucosidase activities by tea polyphenols</article-title><source>Biosci. Biotechnol. Biochem.</source><year>1993</year><volume>57</volume><fpage>123</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1271/bbb.57.123</pub-id><?supplied-pmid 27316886?><pub-id pub-id-type="pmid">27316886</pub-id></element-citation></ref><ref id="B115-molecules-25-04145"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata</surname><given-names>R.</given-names></name><name><surname>Cristians</surname><given-names>S.</given-names></name><name><surname>Escand&#x000f3;n-Rivera</surname><given-names>S.M.</given-names></name><name><surname>Ju&#x000e1;rez-Reyes</surname><given-names>K.</given-names></name><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name></person-group><article-title>Mexican antidiabetic herbs: Valuable sources of inhibitors of &#x003b1;-glucosidases</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>468</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1021/np300869g</pub-id><?supplied-pmid 23398496?><pub-id pub-id-type="pmid">23398496</pub-id></element-citation></ref><ref id="B116-molecules-25-04145"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Sousa</surname><given-names>E.</given-names></name><name><surname>Zanatta</surname><given-names>L.</given-names></name><name><surname>Seifriz</surname><given-names>I.</given-names></name><name><surname>Creczynski-Pasa</surname><given-names>T.B.</given-names></name><name><surname>Pizzolatti</surname><given-names>M.G.</given-names></name><name><surname>Szpoganicz</surname><given-names>B.</given-names></name><name><surname>Silva</surname><given-names>F.R.M.B.</given-names></name></person-group><article-title>Hypoglycemic effect and antioxidant potential of kaempferol-3,7-o-(&#x003b1;)-dirhamnoside from <italic>Bauhinia forficate</italic> leaves</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>829</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1021/np030513u</pub-id><?supplied-pmid 15165145?><pub-id pub-id-type="pmid">15165145</pub-id></element-citation></ref><ref id="B117-molecules-25-04145"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>C.N.V.</given-names></name><name><surname>Suma</surname><given-names>S.M.</given-names></name><name><surname>Banerji</surname><given-names>A.</given-names></name><name><surname>Gopalakrishnapillai</surname><given-names>A.</given-names></name></person-group><article-title>Kaempferitrin inhibits GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2009</year><volume>380</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.01.008</pub-id><pub-id pub-id-type="pmid">19146827</pub-id></element-citation></ref><ref id="B118-molecules-25-04145"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S.</given-names></name><name><surname>Krishnan</surname><given-names>M.</given-names></name><name><surname>Rajagopal</surname><given-names>P.</given-names></name><name><surname>Periyasamy</surname><given-names>V.</given-names></name><name><surname>Veeraraghavan</surname><given-names>V.</given-names></name><name><surname>Govindan</surname><given-names>R.</given-names></name><name><surname>Jayaraman</surname><given-names>S.</given-names></name></person-group><article-title>Beta-sitosterol attenuates insulin resistance in adipose tissue via IRS-1/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats</article-title><source>Eur. J. Pharmacol.</source><year>2020</year><volume>873</volume><fpage>173004</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173004</pub-id><?supplied-pmid 32045603?><pub-id pub-id-type="pmid">32045603</pub-id></element-citation></ref><ref id="B119-molecules-25-04145"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qadan</surname><given-names>F.</given-names></name><name><surname>Verspohl</surname><given-names>E.J.</given-names></name><name><surname>Nahrstedt</surname><given-names>A.</given-names></name><name><surname>Petereit</surname><given-names>F.</given-names></name><name><surname>Matalka</surname><given-names>K.</given-names></name></person-group><article-title>Cinchonain Ib isolated from <italic>Eriobotrya japonica</italic> induces insulin secretion in vitro and in vivo</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>124</volume><fpage>224</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.04.023</pub-id><pub-id pub-id-type="pmid">19397981</pub-id></element-citation></ref><ref id="B120-molecules-25-04145"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szkudelski</surname><given-names>T.</given-names></name><name><surname>Szkudelska</surname><given-names>K.</given-names></name></person-group><article-title>Anti-diabetic effects of resveratrol</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2011</year><volume>1215</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05844.x</pub-id><pub-id pub-id-type="pmid">21261639</pub-id></element-citation></ref><ref id="B121-molecules-25-04145"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmers</surname><given-names>S.</given-names></name><name><surname>De Ligt</surname><given-names>M.</given-names></name><name><surname>Phielix</surname><given-names>E.</given-names></name><name><surname>Van De Weijer</surname><given-names>T.</given-names></name><name><surname>Hansen</surname><given-names>J.</given-names></name><name><surname>Moonen-Kornips</surname><given-names>E.</given-names></name><name><surname>Schaart</surname><given-names>G.</given-names></name><name><surname>Kunz</surname><given-names>I.</given-names></name><name><surname>Hesselink</surname><given-names>M.K.C.</given-names></name><name><surname>Schrauwen-Hinderling</surname><given-names>V.B.</given-names></name></person-group><article-title>Resveratrol as add-on therapy in subjects with well-controlled type 2 diabetes: A randomized controlled trial</article-title><source>Diabetes Care</source><year>2016</year><volume>39</volume><fpage>2211</fpage><lpage>2217</lpage><pub-id pub-id-type="doi">10.2337/dc16-0499</pub-id><pub-id pub-id-type="pmid">27852684</pub-id></element-citation></ref><ref id="B122-molecules-25-04145"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khursheed</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>S.K.</given-names></name><name><surname>Wadhwa</surname><given-names>S.</given-names></name><name><surname>Kapoor</surname><given-names>B.</given-names></name><name><surname>Gulati</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Ramanunny</surname><given-names>A.K.</given-names></name><name><surname>Awasthi</surname><given-names>A.</given-names></name><name><surname>Dua</surname><given-names>K.</given-names></name></person-group><article-title>Treatment strategies against diabetes: Success so far and challenges ahead</article-title><source>Eur. J. Pharmacol.</source><year>2019</year><volume>862</volume><fpage>172625</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172625</pub-id><pub-id pub-id-type="pmid">31449807</pub-id></element-citation></ref><ref id="B123-molecules-25-04145"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nenquin</surname><given-names>M.</given-names></name><name><surname>Henquin</surname><given-names>J.C.</given-names></name></person-group><article-title>Sulphonylurea receptor-1, sulphonylureas and amplification of insulin secretion by Epac activation in &#x003b2; cells</article-title><source>Diabetes Obes. Metab.</source><year>2016</year><volume>18</volume><fpage>698</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1111/dom.12607</pub-id><?supplied-pmid 26584950?><pub-id pub-id-type="pmid">26584950</pub-id></element-citation></ref><ref id="B124-molecules-25-04145"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>J.S.</given-names></name><name><surname>Graven</surname><given-names>L.J.</given-names></name></person-group><article-title>Progressing from metformin to sulfonylureas or meglitinides</article-title><source>Workplace Health Saf.</source><year>2016</year><volume>64</volume><fpage>433</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1177/2165079916644263</pub-id><?supplied-pmid 27621259?><pub-id pub-id-type="pmid">27621259</pub-id></element-citation></ref><ref id="B125-molecules-25-04145"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>E.S.</given-names></name><name><surname>Deacon</surname><given-names>C.F.</given-names></name><name><surname>Holst</surname><given-names>J.J.</given-names></name></person-group><article-title>Do we know the true mechanism of action of the DPP-4 inhibitors?</article-title><source>Diabetes Obes. Metab.</source><year>2018</year><volume>20</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1111/dom.13018</pub-id><?supplied-pmid 28544214?><pub-id pub-id-type="pmid">28544214</pub-id></element-citation></ref><ref id="B126-molecules-25-04145"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>A.</given-names></name><name><surname>Lund</surname><given-names>A.</given-names></name><name><surname>Knop</surname><given-names>F.K.</given-names></name><name><surname>Vilsb&#x000f8;ll</surname><given-names>T.</given-names></name></person-group><article-title>Glucagon-like peptide 1 in health and disease</article-title><source>Nat. Rev. Endocrinol.</source><year>2018</year><volume>14</volume><fpage>390</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1038/s41574-018-0016-2</pub-id><pub-id pub-id-type="pmid">29728598</pub-id></element-citation></ref><ref id="B127-molecules-25-04145"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name><name><surname>Cristians</surname><given-names>S.</given-names></name><name><surname>Ovalle-Magallanes</surname><given-names>B.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Mexican copalchis of the Rubiaceae family: More than a century of pharmacological and chemical investigations</article-title><source>Phytochem. Rev.</source><year>2019</year><volume>18</volume><fpage>1435</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1007/s11101-019-09618-y</pub-id></element-citation></ref><ref id="B128-molecules-25-04145"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Synthesis and biological evaluation of novel neoflavonoid derivatives as potential antidiabetic agents</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>34448</fpage><lpage>34460</lpage><pub-id pub-id-type="doi">10.1039/C7RA06457H</pub-id></element-citation></ref><ref id="B129-molecules-25-04145"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>A.</given-names></name><name><surname>Nishiumi</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>K.-I.</given-names></name><name><surname>Ashida</surname><given-names>H.</given-names></name></person-group><article-title>Rat L6 myotubes as an in vitro model system to study GLUT4-dependent glucose uptake stimulated by inositol derivatives</article-title><source>Cytotechnology</source><year>2007</year><volume>55</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1007/s10616-007-9107-y</pub-id><pub-id pub-id-type="pmid">19002999</pub-id></element-citation></ref><ref id="B130-molecules-25-04145"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><name><surname>Zhao</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Discovery of novel insulin sensitizers: Promising approaches and targets</article-title><source>PPAR Res.</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2017/8360919</pub-id></element-citation></ref><ref id="B131-molecules-25-04145"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanjan</surname><given-names>M.</given-names></name><name><surname>Mohammed</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>B.R.P.</given-names></name><name><surname>Chandrasekar</surname><given-names>M.</given-names></name></person-group><article-title>Thiazolidinediones as antidiabetic agents: A critical review</article-title><source>Bioorganic Chem.</source><year>2018</year><volume>77</volume><fpage>548</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2018.02.009</pub-id></element-citation></ref><ref id="B132-molecules-25-04145"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>M.A.</given-names></name><name><surname>Mattison</surname><given-names>D.R.</given-names></name><name><surname>Azoulay</surname><given-names>L.</given-names></name><name><surname>Krewski</surname><given-names>D.</given-names></name></person-group><article-title>Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: Past, present and future</article-title><source>Crit. Rev. Toxicol.</source><year>2017</year><volume>48</volume><fpage>52</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1080/10408444.2017.1351420</pub-id><pub-id pub-id-type="pmid">28816105</pub-id></element-citation></ref><ref id="B133-molecules-25-04145"><label>133.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guyton</surname><given-names>A.C.</given-names></name><name><surname>Hall</surname><given-names>J.E.</given-names></name></person-group><source>Textbook of Medical Physiology</source><edition>11th ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Philadelphia, PA, USA</publisher-loc><year>2006</year></element-citation></ref><ref id="B134-molecules-25-04145"><label>134.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>DeFronzo</surname><given-names>R.A.</given-names></name><name><surname>Mandarino</surname><given-names>L.</given-names></name><name><surname>Ferrannini</surname><given-names>E.</given-names></name></person-group><article-title>Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus</article-title><source>International Textbook of Diabetes Mellitus</source><person-group person-group-type="editor"><name><surname>DeFronzo</surname><given-names>R.A.</given-names></name><name><surname>Ferrannini</surname><given-names>E.</given-names></name><name><surname>Keen</surname><given-names>H.</given-names></name><name><surname>Zimet</surname><given-names>P.</given-names></name></person-group><publisher-name>Wiley</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2003</year></element-citation></ref><ref id="B135-molecules-25-04145"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>R.W.</given-names></name><name><surname>Hughey</surname><given-names>C.C.</given-names></name><name><surname>Lantier</surname><given-names>L.</given-names></name><name><surname>Sundelin</surname><given-names>E.I.O.</given-names></name><name><surname>Peggie</surname><given-names>M.</given-names></name><name><surname>Zeqiraj</surname><given-names>E.</given-names></name><name><surname>Sicheri</surname><given-names>F.</given-names></name><name><surname>Jessen</surname><given-names>N.</given-names></name><name><surname>Wasserman</surname><given-names>D.H.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name></person-group><article-title>Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase</article-title><source>Nat. Med.</source><year>2018</year><volume>24</volume><fpage>1395</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0159-7</pub-id><?supplied-pmid 30150719?><pub-id pub-id-type="pmid">30150719</pub-id></element-citation></ref><ref id="B136-molecules-25-04145"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname><given-names>A.</given-names></name><name><surname>Altman</surname><given-names>U.G.</given-names></name><name><surname>Tetzlaff</surname><given-names>J.</given-names></name><name><surname>Mulrow</surname><given-names>C.</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>P.C.</given-names></name><name><surname>Ioannidis</surname><given-names>J.P.A.</given-names></name><name><surname>Clarke</surname><given-names>M.</given-names></name><name><surname>Devereaux</surname><given-names>P.J.</given-names></name><name><surname>Kleijnen</surname><given-names>J.</given-names></name><name><surname>Moher</surname><given-names>D.</given-names></name></person-group><article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration</article-title><source>BMJ</source><year>2009</year><volume>339</volume><fpage>b2700</fpage><pub-id pub-id-type="doi">10.1136/bmj.b2700</pub-id><?supplied-pmid 19622552?><pub-id pub-id-type="pmid">19622552</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-04145-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flavonoids from Mexican plants with hypoglycemic activity.</p></caption><graphic xlink:href="molecules-25-04145-g001"/></fig><fig id="molecules-25-04145-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Aromatic compounds, other than flavonoids, from Mexican plants with hypoglycemic activity.</p></caption><graphic xlink:href="molecules-25-04145-g002"/></fig><fig id="molecules-25-04145-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Terpenoids and steroids from Mexican plants with hypoglycemic activity.</p></caption><graphic xlink:href="molecules-25-04145-g003"/></fig><fig id="molecules-25-04145-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Carbohydrates and a cyclitol from Mexican plants with hypoglycemic activity.</p></caption><graphic xlink:href="molecules-25-04145-g004"/></fig><table-wrap id="molecules-25-04145-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04145-t001_Table 1</object-id><label>Table 1</label><caption><p>Isolated Compounds from Hypoglycemic Mexican plants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant/Family/Part</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isolated Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acacia angustissima</italic> (Mill.) Kuntze (Fabaceae)/Pods.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protocatechuic acid (<bold>1</bold>); catechin (<bold>2</bold>); <italic>&#x003c1;</italic>-coumaric acid (<bold>3</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B12-molecules-25-04145" ref-type="bibr">12</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acourtia thurberi</italic> (A.Gray) Reveal &#x00026; R.M.King (Asteraceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Perezone (<bold>4</bold>); &#x003b1;-pipitzol (<bold>5</bold>); &#x003b2;-pipitzol (<bold>6</bold>); 8-&#x003b2;-<sc>d</sc>-glucopyranosyloxy-4-methoxy-5-methyl-coumarin (<bold>7</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-molecules-25-04145" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acosmium panamense</italic> (Benth.) Yacolev (Fabaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Desmethylyangonine (<bold>8</bold>); desmethylangonine-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>9</bold>); desmethylangonine-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-(1&#x02192;6)-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>10</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B14-molecules-25-04145" ref-type="bibr">14</xref>,<xref rid="B15-molecules-25-04145" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Agarista mexicana</italic> (Hemsl.) Judd. (Ericaceae)/Bark.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-Ursene (<bold>11</bold>); 23,24-dimethyl-24-ethyl-stigmast-25-ene (<bold>12</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B16-molecules-25-04145" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-04145" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ageratina petiolaris</italic> (Moc. &#x00026; Sess&#x000e9; ex DC.) R. M. King &#x00026; H. Rob (Asteraceae)/Aerial parts. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorogenic acid (<bold>13</bold>); L-<italic>chiro</italic>-inositol (<bold>14)</bold>; 2&#x003b1;-<italic>iso</italic>-valeroyloxyeperuic acid (<bold>15</bold>); benzyl-2-hydroxy-6-methoxybenzoate (<bold>16</bold>); benzyl-2,6-dimethoxybenzoate (<bold>17</bold>); 3-methoxybenzyl 2,6-dimethoxybenzoate (<bold>18</bold>); benzyl-2-hydroxy-3,6-dimethoxybenzoate (<bold>19</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B18-molecules-25-04145" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Annona cherimola</italic> Mill (Annonaceae)/Leaves.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rutin (<bold>20</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-molecules-25-04145" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Anoda cristata (L.)</italic> Schltdl. (Malvaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acacetin (<bold>21</bold>); diosmetin (<bold>22</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-molecules-25-04145" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Artemisia ludoviciana</italic> Nutt (Asteraceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eupatilin (<bold>23</bold>); jaceosidin (<bold>24</bold>); arglanin (<bold>25</bold>); salvinine (<bold>26</bold>);<break/>3,5-<italic>di</italic>-<italic>O</italic>-caffeoylquinic acid (<bold>27</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-25-04145" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Arracacia tolucensis</italic> (Kunth) Hemsl. (Apiaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>S</italic>)-(+)-4&#x02032;-<italic>O</italic>-angeloylvisamminol (<bold>28</bold>); praeruptorin A (<bold>29</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-molecules-25-04145" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Brickellia veronicaefolia</italic> (Khunt) Gray (Asteraceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,7,3&#x02032;-Trihydroxy-3,6,4&#x02032;-trimethoxyflavone (<bold>30</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-molecules-25-04145" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-04145" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bromelia karatas</italic> (L) (Bromeliaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Sitosterol-3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>31</bold>); <italic>&#x003c1;</italic>-coumaric acid (<bold>3</bold>); cirsiliol-4&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>32</bold>); stigmasterol (<bold>33</bold>); &#x003b2;-sitosterol (<bold>34</bold>); 1-<italic>O</italic>-feruloyl-3-<italic>O</italic>-<italic>&#x003c1;</italic>-coumaroylglycerol (<bold>35</bold>); &#x003b2;-<sc>d</sc>-(1-<italic>O</italic>-acetyl-3,6-<italic>O</italic>-<italic>trans</italic>-diferuloyl)-fructofuranosyl-&#x003b1;-<sc>d</sc>-2&#x02032;,4&#x02032;,6&#x02032;-<italic>O</italic>-triacetyl-glucopyranoside (<bold>36</bold>); 1-<italic>O</italic>-<italic>&#x003c1;</italic>-coumaroyl-3-<italic>O</italic>-caffeoylglycerol (<bold>37</bold>); 2-propyl-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>38</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B26-molecules-25-04145" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-04145" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Calea oliveri</italic> B.L.Rob. &#x00026; Greenm (Asteraceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-Acetyl-5-hydroxy-2,2-dimethyl-<italic>2H</italic>-chromene (<bold>39</bold>); 6-hydroxyacetyl-5-hydroxy-2,2-dimethyl-<italic>2H</italic>-chromene (<bold>40</bold>); 6-acetyl-5-hydroxy-2-methyl-2-hydroxymethyl-<italic>2H</italic>-chromene (<bold>41</bold>); caleins A (<bold>42</bold>) and C (<bold>43</bold>); genkwanin (<bold>44</bold>); isorhamnetin (<bold>45</bold>); kaempferol (<bold>46</bold>); quercetin (<bold>47</bold>); herniarin (<bold>48</bold>); scoparone (<bold>49</bold>); 4&#x02032;,7-dimethylapigenin (<bold>50</bold>); curcumene (<bold>51</bold>); spathulenol (<bold>52</bold>); caryophyllene oxide (<bold>53</bold>). acacetin (<bold>21</bold>); 3,5-<italic>di</italic>-<italic>O</italic>-caffeoylquinic acid (<bold>27</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-molecules-25-04145" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-04145" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cecropia obtusifolia</italic> Bertol. (Urticaceae)/Leaves.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorogenic acid (<bold>13</bold>); isoorientin (<bold>54</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-25-04145" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-04145" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-04145" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cochlospermum vitifolium</italic> (Willd) (Bixaceae)/Bark.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x000b1;)-Naringenin (<bold>55</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-molecules-25-04145" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-04145" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Coriandrum sativum L.</italic> (Apiaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rutin (<bold>20</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-molecules-25-04145" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cucurbita ficifolia Bouch&#x000e9;</italic> (Cucurbitaceae)/Fresh mature and immature fruits.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>&#x003c1;</italic>-Coumaric acid (<bold>3</bold>); stigmast-7,22-dien-3-ol (<bold>56</bold>); salicin (<bold>57</bold>); stigmast-7-en-3-ol (<bold>58</bold>); <italic>&#x003c1;</italic>-hydroxybenzoic acid (<bold>59</bold>). </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-molecules-25-04145" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-04145" ref-type="bibr">38</xref>,<xref rid="B39-molecules-25-04145" ref-type="bibr">39</xref>,<xref rid="B40-molecules-25-04145" ref-type="bibr">40</xref>,<xref rid="B41-molecules-25-04145" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Equisetum myriochaetum</italic> Schlecht. &#x00026; Cham. (Equisetaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol-3-<italic>O</italic>-sophoroside (<bold>60</bold>); kaempferol-3,7-<italic>di</italic>-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>61</bold>); kaempferol-3-<italic>O</italic>-sophoroside-4&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>62</bold>); caffeoyl-methylate-4-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>63</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>,<xref rid="B42-molecules-25-04145" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-04145" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-04145" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eysenhardtia platycarpa</italic> Pennell &#x00026; Saff. (Fabaceae)/Leaves, branches and bark.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1&#x02033;<italic>R</italic>)-5,4&#x02032;,1&#x02033;-Trihydroxy- 6,7-(3&#x02033;,3&#x02033;-dimethyl chroman) flavone (<bold>64</bold>); 5,7-dihydroxy-6-methyl-8-prenyl flavanone (<bold>65</bold>); 5,7-dihydroxy-8-methyl-6-prenyl flavanone (<bold>66</bold>); 5,7-dihydroxy-6-prenylflavanone (<bold>67</bold>); 5,7-dihydroxy-8-prenylflavanone (<bold>68</bold>); 3-<italic>O</italic>-acetyloleanolic acid (<bold>69</bold>); oleanolic acid (<bold>70</bold>); 3&#x003b2;-acetoxy-11&#x003b1;,12&#x003b1;-epoxy-oleanan-28,13&#x003b2;-olide (<bold>71</bold>); lupeol (<bold>72</bold>); betulinic acid (<bold>73</bold>); &#x003b2;-sitosterol (<bold>34</bold>); &#x003b2;-sitosterol-3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>31</bold>); &#x003b2;-sitosteryl palmitate (<bold>74</bold>); 3-<italic>O</italic>-methyl-<italic>myo</italic>-inositol (<bold>75</bold>); (+)-catechin (<bold>2</bold>); (2<italic>S</italic>)-4&#x02032;-<italic>O</italic>-methyl-6-methyl-8-prenyl-naringenin (<bold>76</bold>); 3,4,6,4&#x02032;-<italic>O</italic>-methyl-8-prenylnaringenin (<bold>77</bold>); 5-hydroxy-7-methoxy-8-prenyl-flavanone (<bold>78</bold>); (+)-catechin 3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-galactopyranoside (<bold>79</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-molecules-25-04145" ref-type="bibr">45</xref>,<xref rid="B46-molecules-25-04145" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eysenhardtia polystachya</italic> (Ortega) Sarg. (Fabaceae)/Leaves and bark.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02032;,4&#x02032;-Dihydroxychalcone-6&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>80</bold>); &#x003b1;,3,2&#x02032;,4&#x02032;-tetrahydroxy-4-methoxydihydrochalcone-3&#x02032;-<italic>C</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-6&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>81</bold>); 7-hydroxy-5,8&#x02032;-dimethoxy-6&#x02032;&#x003b1;-<sc>l</sc>-rhamnopyranosyl-8-(3-phenyl-trans-acryloyl)-1-benzopyran-2-one (<bold>82</bold>); 6&#x02032;,7-dihydroxy-5,8-dimethoxy-8(3-phenyl-trans-acryloyl)-1-benzopyran-2-one (<bold>83</bold>); 9-hydroxy-3,8-dimethoxy-4-prenyl-pterocarpan (<bold>84</bold>); &#x003b1;,4,4&#x02032;-trihydroxydihydro-chalcone-2&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>85</bold>); 5,4&#x02032;-dihydroxy-7,2&#x02032;-dimethoxylisoflavone (<bold>86</bold>); (<italic>3R</italic>)-5,7-2&#x02032;,4&#x02032;-tetrahydroxyl-3&#x02032;-methoxylisoflavanone (<bold>87</bold>); flemichapparin C (<bold>88</bold>); <italic>neo</italic>-hesperidin dihydrochalcone (<bold>89</bold>); hesperetin dihydrochalcone-glucoside (<bold>90</bold>); aspalathin (<bold>91</bold>); sandwicensis (<bold>92</bold>); 6&#x02032;-methoxy-sieboldin (<bold>93</bold>); 2&#x02032;-<italic>O</italic>-&#x003b1;-<sc>l</sc>-rhamnopyranosyl-&#x003b1;,6&#x02032;-dihydroxy-4&#x02032;-acetyl-4-methoxydihydro-chalcone (<bold>94</bold>); 2&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-4&#x02032;-methoxy-4-hydroxy-3-isoprenyldihydrochalcone (<bold>95</bold>); 2&#x02032;,4&#x02032;,6&#x02032;-trihydroxy-4,5-dimethoxy-3-isoprenyldihydrochalcone (<bold>96</bold>); 3&#x02032;-<italic>C</italic>-&#x003b2;-glucopyranosyl-&#x003b1;,2&#x02032;,4&#x02032;,6&#x02032;-trihydroxy-4-methoxy-dihydrochalcone (<bold>97</bold>); 3&#x02032;-<italic>C</italic>-&#x003b2;-glucopyranosyl-&#x003b1;,2&#x02032;,4-trihydroxy-4&#x02032;,6&#x02032;-dimethoxy-dihydrochalcone (<bold>98</bold>); 3-hydroxyphloretin-4&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>99</bold>); 3,4&#x02032;-dihydroxy-2,4,6-trimethoxy-dihydrochalcone (<bold>100</bold>); 2&#x02032;,4&#x02032;,4- trihydroxy-3&#x02032;-methoxy-dihydrochalcone (<bold>101);</bold> 2&#x02032;,4&#x02032;,6&#x02032;,4-tetrahydroxy-3,5-diisoprenyldihydrochalcone (<bold>102</bold>); 3&#x02032;-<italic>C</italic>-&#x003b2;-glucopyranosyl-&#x003b1;,2&#x02032;,4&#x02032;,3,4-pentahydroxydihydroxychalcone (<bold>103</bold>); 3&#x02032;-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-&#x003b1;,4,2&#x02032;,4,6&#x02032;-pentahydroxy-dihydrochalcone (<bold>104</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-molecules-25-04145" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-04145" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-04145" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-04145" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-04145" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Exostema caribaeum</italic> (Jacq.) Schult. (Rubiaceae)/Stem bark.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorogenic acid (<bold>13</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-xylopyranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7,3&#x02032;,4&#x02032;-trihydroxy-4-phenylcoumarin (<bold>105</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-7,3&#x02032;,4&#x02032;-trihydroxy-4-phenylcoumarin (<bold>106</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-xylopyranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>107</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-galactopyranosyl-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>108</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>109</bold>); 5-<italic>O</italic>-(6&#x02032;-acetyl-&#x003b2;-<sc>d</sc>-glucopyranosyl)-7,3&#x02032;,4&#x02032;-trihydroxy-4-phenylcoumarin (<bold>110</bold>); 5-<italic>O</italic>-(6&#x02032;-acetyl-&#x003b2;-<sc>d</sc>-galactopyranosyl)-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>111</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-molecules-25-04145" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hamelia patens</italic> Jacq. (Rubiaceae)/Aerial parts and leaves.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not isolated but identified chlorogenic acid (<bold>13</bold>); quercetin (<bold>47</bold>); caffeic acid (<bold>112</bold>); epicatechin (<bold>113</bold>); catechin (<bold>2</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-molecules-25-04145" ref-type="bibr">53</xref>,<xref rid="B54-molecules-25-04145" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hintonia latiflora</italic> (Sess&#x000e9; &#x00026; Moc. ex DC.) Bullock (Rubiaceae)/Stem bark and leaves/endophytic fungus </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-Glucopyranosyl-7,3&#x02032;,4&#x02032;-trihydroxy-4-phenylcoumarin (<bold>106</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-xylopyranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>107</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-galactopyranosyl-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>108</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>109</bold>); 25-<italic>O</italic>-acetyl-3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-23,24-dihydrocucurbitacin F (<bold>114</bold>); 3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-23,24-dihydrocucurbitacin F (<bold>115</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-apiofuranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>116</bold>); desoxycordifolinic acid (<bold>117</bold>); ursolic acid (<bold>118</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-xylopyranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7,4&#x02032;-dimethoxy-4-phenylcoumarin (<bold>119</bold>); chlorogenic acid (<bold>13</bold>); thielavins A (<bold>120</bold>), J (<bold>121</bold>) and K (<bold>122</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-molecules-25-04145" ref-type="bibr">55</xref>,<xref rid="B56-molecules-25-04145" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-04145" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-04145" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hintonia standleyana</italic> Bullock (Rubiaceae)/Stem bark and leaves.<break/>This taxon is a synonym of; Hintonia latiflora (Sess&#x000e9; &#x00026; Moc. ex DC.)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25-<italic>O</italic>-Acetyl-3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-23,24-dihydrocucurbitacin F (<bold>114</bold>); 3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-23,24-dihydrocucurbitacin F (<bold>115</bold>); 5-<italic>O</italic>-[&#x003b2;-<sc>d</sc>-apiofuranosyl-(1&#x02192;6)-&#x003b2;-<sc>d</sc>-glucopyranosyl]-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>116</bold>); 5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranosyl-7-methoxy-3&#x02032;,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>109</bold>); 6&#x02033;-<italic>O</italic>-acetyl-5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-galactopyranosyl-7,4&#x02032;-dihydroxy-4-phenylcoumarin (<bold>123</bold>); 6&#x02033;-<italic>O</italic>-acetyl-5-<italic>O</italic>-&#x003b2;-<sc>d</sc>-galactopyranosyl-7,3&#x02032;,4&#x02032;-trihydroxy-4-phenylcoumarin (<bold>124</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-molecules-25-04145" ref-type="bibr">56</xref>,<xref rid="B59-molecules-25-04145" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ibervillea sonorae</italic> (S. Watson) Greene (Cucurbitaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-Monopalmitin (<bold>125</bold>); glyceryl-1-monomargarate (<bold>126</bold>); 1-monostearin (<bold>127</bold>); glyceryl-1-monononadecylate (<bold>128</bold>); glyceryl-1-monoarachidate (<bold>129</bold>); glyceryl-1-monobehenate (<bold>130</bold>); glyceryl-1-monotricosanoate (<bold>131</bold>); glyceryl-1-monotetracosanoate (<bold>132</bold>); glyceryl-1-monopentacosanoate (<bold>133</bold>); glyceryl-1-monohexacosanoate (<bold>134</bold>); glyceryl-1-monooctacosanoate (<bold>135</bold>); lauric acid (<bold>136</bold>); myristic acid (<bold>137</bold>); pentadecanoic acid (<bold>138</bold>); palmitic acid (<bold>139</bold>); stearic acid (<bold>140</bold>); gallic acid (<bold>141</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-molecules-25-04145" ref-type="bibr">60</xref>,<xref rid="B61-molecules-25-04145" ref-type="bibr">61</xref>,<xref rid="B62-molecules-25-04145" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-04145" ref-type="bibr">63</xref>,<xref rid="B64-molecules-25-04145" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ipomoea pes-caprae</italic> (L.) R. Br and Ipomoea purga (Wender.) Hayne (Convolvulaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pescapreins I (<bold>142</bold>), III (<bold>143</bold>), V (<bold>144</bold>) and IX (<bold>145</bold>); stolonoferins I (<bold>146</bold>) and III (<bold>147</bold>); murucoidins IV (<bold>148</bold>), V (<bold>149),</bold> XIV (<bold>150</bold>), XVIII (<bold>151</bold>), XIX (<bold>152</bold>) and XX (<bold>153</bold>); purginosides I (<bold>154</bold>), II (<bold>155</bold>) and IV (<bold>156</bold>); purgins I (<bold>157</bold>), II (<bold>158</bold>) and III (<bold>159</bold>); tricolorins A (<bold>160</bold>), E (<bold>161</bold>) and I (<bold>162</bold>); wolcottines I (<bold>163</bold>), I (<bold>164</bold>), II (<bold>165</bold>), III (<bold>166</bold>) and IV (<bold>167</bold>); intrapilosin VII (<bold>168</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-molecules-25-04145" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Justicia spicigera</italic> Schltdl (Acanthaceae)/Leaves.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferitrin (<bold>169</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-molecules-25-04145" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ligusticum porteri</italic> J.M. Coult. &#x00026; Rose (Apiaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>Z</italic>)-6,6&#x02032;,7,3&#x02032;&#x003b1;-Diligustilide (<bold>170</bold>); (<italic>Z</italic>)-ligustilide (<bold>171</bold>); 3-(<italic>Z</italic>)-butylidenephthalide (<bold>172</bold>); myristicin (<bold>173</bold>), Ferulic acid (<bold>174</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-molecules-25-04145" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Melampodium perfoliatum</italic> (Cav.) Kunth (Asteraceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Perfoliatin A (<bold>175</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-molecules-25-04145" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mosannona depressa</italic> (Baill.) Chatrou (Annonaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-Hydroxy-3,4,5-trimethoxy-1-(2&#x02032;,4&#x02032;-hydroxy-3&#x02032;-dihydroxy) butylbenzene (<bold>176</bold>); 2-hydroxy-3,4,5-trimethoxy-1-(2&#x02032;,3&#x02032;,4&#x02032;-hydroxy) butyl-benzene (<bold>177</bold>); 3-(3-hydroxy-2,4,5-trimethoxyphenyl) propane-1,2 diol (<bold>178</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>,<xref rid="B69-molecules-25-04145" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-04145" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-04145" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Opuntia streptacantha</italic> Lem. (Cactaceae)/Cladodes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-Hydroxyphenylacetic acid (<bold>179</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-molecules-25-04145" ref-type="bibr">72</xref>,<xref rid="B73-molecules-25-04145" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Psacalium decompositum</italic> (A.Gray) H.Rob. &#x00026; Brettell (Asteraceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacalol (<bold>180</bold>); cacalol acetate (<bold>181</bold>); cacalone (<bold>182</bold>); maturin (<bold>183</bold>); maturinone (<bold>184</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-molecules-25-04145" ref-type="bibr">74</xref>,<xref rid="B75-molecules-25-04145" ref-type="bibr">75</xref>,<xref rid="B76-molecules-25-04145" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-04145" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Psacalium paucicapitatum</italic> (B.L.Rob. &#x00026; Greenm.) H.Rob. &#x00026; Brettell (Asteraceae)/Corms.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kestose (<bold>185</bold>); nystose (<bold>186</bold>); fructofuranosyl-nystose (<bold>187</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-molecules-25-04145" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Phoradendron reichenbachianum</italic> (Seem.) Oliv. (Santalaceae)/Leaves and stems.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moronic acid (<bold>188</bold>); morolic acid (<bold>189</bold>); oleanolic acid (<bold>70</bold>); ursolic acid (<bold>118</bold>); 3,4-seco-olean-18-ene-3,28-dioic acid (<bold>190</bold>); &#x003b1;-amyrin (<bold>191</bold>); &#x003b2;-amyrin (<bold>192</bold>); oleanolic aldehyde (<bold>193</bold>); lupeol (<bold>72</bold>); lupenone (<bold>194</bold>); betulin aldehyde (<bold>195</bold>); betulon aldehyde (<bold>196</bold>); betulinic acid (<bold>73</bold>); acacetin (<bold>21</bold>); betulonic acid (<bold>197</bold>); squalene (<bold>198</bold>); triacontanol (<bold>199</bold>); &#x003b2;-sitosteryl linoleate (<bold>200</bold>); stigmasteryl linoleate (<bold>201</bold>); &#x003b2;-sitosterol (<bold>34</bold>); stigmasterol (<bold>33</bold>); acacetin 7-methyl ether (<bold>202</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-molecules-25-04145" ref-type="bibr">79</xref>,<xref rid="B80-molecules-25-04145" ref-type="bibr">80</xref>,<xref rid="B81-molecules-25-04145" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rhizophora</italic> mangle L. (Rizophoraceae)/Cortex.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinchonains Ia (<bold>203</bold>) and Ib (<bold>204</bold>); epicatechin (<bold>113</bold>); catechin-3-<italic>O</italic>-rhamnopyranoside (<bold>205</bold>); lyoniside (<bold>206</bold>); nudiposide (<bold>207</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B82-molecules-25-04145" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-04145" ref-type="bibr">83</xref>,<xref rid="B84-molecules-25-04145" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salvia circinnata</italic> Cav. (Lamiaceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,6&#x02033;,3&#x02033;-Trihydroxy-7,3&#x02032;,7&#x02032;-<italic>O</italic>-trimethyl-loniflavon (<bold>208</bold>); amarisolides B (<bold>209</bold>), C (<bold>210</bold>), D (<bold>211</bold>) and E (<bold>212</bold>); amarisolide (<bold>213</bold>); pedalitin (<bold>214</bold>); apigenin-7-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside (<bold>215</bold>); 2-(3,4-dimethoxy-phenyl)-5,6-dihydroxy-7-methoxy-<italic>4H</italic>-chromen-4-one (<bold>216</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-molecules-25-04145" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Smilax aristolochiifolia</italic> Mill. (Smilaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-<italic>trans</italic>-Feruloyltyramine (<bold>217</bold>); astilbin (<bold>218</bold>); chlorogenic acid (<bold>13</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-molecules-25-04145" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-04145" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Smilax moranensis</italic> M. Martens &#x00026; Galeotti (Smilaceae)/Roots.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Resveratrol (<bold>219</bold>); 5-<italic>O</italic>-caffeoylquinic acid (<bold>220</bold>); chlorogenic acid (<bold>13</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B84-molecules-25-04145" ref-type="bibr">84</xref>,<xref rid="B88-molecules-25-04145" ref-type="bibr">88</xref>,<xref rid="B89-molecules-25-04145" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Swietenia humilis</italic> Zucc (Melaiceae)/Seeds.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-Hydroxy-destigloyl-6-deoxyswietenine acetate (<bold>221</bold>)<sup>;</sup> humulin B (<bold>222</bold>); methyl-2-hydroxy-3-&#x003b2;-isobutyroxy-1-oxomeliac-8(30)-enate (<bold>223</bold>); methyl-2-hydroxy-3-&#x003b2;-tigloyloxy-1-oxomeliac-8(30)-enate (<bold>224</bold>); humilinolide G (<bold>225</bold>); humilinolide C (<bold>226</bold>); methyl-2-hydroxy-3-&#x003b2;-isobutyloyl-8&#x003b1;,30&#x003b1;-epoxy-1-oxo-meliacate (<bold>227</bold>); humilinolide H (<bold>228</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-molecules-25-04145" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-04145" ref-type="bibr">91</xref>,<xref rid="B92-molecules-25-04145" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tecoma stans</italic> (L.) Juss. ex Kunth (Bignoniaceae)/Leaves.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chrysoeriol (<bold>229</bold>); apigenin (<bold>230</bold>); luteolin (<bold>231</bold>); verbascoside (<bold>232</bold>); luteolin-7-<italic>O</italic>-glucopyranoside (<bold>233</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-molecules-25-04145" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04145" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Turnera diffusa</italic> Willd. ex Schult. (Passifloraceae)/Aerial.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Teuhetenone A (<bold>234</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-molecules-25-04145" ref-type="bibr">95</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-04145-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04145-t002_Table 2</object-id><label>Table 2</label><caption><p>Activity Found in the Isolated Compounds from Mexican Plants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant/Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Experiment <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AC <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Other Activity Found</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acacia angustissima</italic>/Methanol extract (<bold>ME</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>ME</bold>: AHT (25, 50, and 100 mg/kg of bw) and OGTT (25, 50, and 100 mg/kg of bw) in healthy and STZ-treated rats. BP: TC, TG, LDL and HDL [<xref rid="B12-molecules-25-04145" ref-type="bibr">12</xref>].<break/>In vitro: Lipid peroxidation and protein content in kidney, glucose incorporation assay in adipocytic cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>1</bold>
<break/>
<bold>2</bold>
<break/>
<bold>3</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>1</bold> Decreases blood glucose in diabetic rats; insulin-sensitizing [<xref rid="B96-molecules-25-04145" ref-type="bibr">96</xref>,<xref rid="B97-molecules-25-04145" ref-type="bibr">97</xref>]. <bold>2</bold> is in vitro and in vivo AG inhibitor [<xref rid="B98-molecules-25-04145" ref-type="bibr">98</xref>], and hypoglycemic (CHT), glucose oxidizing and insulin-mimetic agent [<xref rid="B99-molecules-25-04145" ref-type="bibr">99</xref>]. <bold>3</bold> lowers blood glucose level (CHT), glucose-6-phosphatase, and fructose-1,6-bisphosphatase; increases the activities of hexokinase, G6PD, and GSH by increasing level of insulin; reduces the total cholesterol and triglycerides in both plasma and tissues i.e., liver and kidney [<xref rid="B100-molecules-25-04145" ref-type="bibr">100</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acourtia thurberi/</italic>Aque-ous extract<break/>(<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold>: AHT, OGTT, and OSTT in healthy and STZ-treated mice using half-log interval doses (31.6, 100, and 316.2 mg/kg of bw of the extract and 3.2, 10, and 31.6 mg/kg of bw of compounds for all experiments) [<xref rid="B13-molecules-25-04145" ref-type="bibr">13</xref>].<break/>In vitro: <bold>WE</bold>: Y-AG (IC<sub>50</sub> = 566.7 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4</bold>
<sup>(31.6 mg/kg)</sup>
<break/>
<bold>5</bold>
<sup>(3.2-31.6 mg/kg/944.9 &#x003bc;M)</sup>
<break/>
<bold>6</bold>
<sup>(3.2-31.6 mg/kg/944.9 &#x003bc;M)</sup>
<break/>
<bold>7</bold>
<sup>(3.2-31.6 mg/kg/3.98 &#x003bc;M)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acosmium panamense/</italic>Aq-eous (<bold>WE</bold>) and butanol (<bold>BE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold>: AHT (20 and 200 mg/kg of bw) in STZ-treated rats. <bold>BE</bold>: AHT (20 and 100 mg/kg of bw) STZ-treated rats. Dose of compounds <bold>9</bold> and <bold>10</bold> for AHT: 20 mg/kg of bw [<xref rid="B15-molecules-25-04145" ref-type="bibr">15</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>9</bold>
<sup>(20 mg/kg)</sup>
<break/>
<bold>10</bold>
<sup>(20 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Agarista mexicana/</italic>Chlo-roform extract (<bold>CHE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>CHE</bold>: AHT in healthy (150 mg/kg of bw) and alloxan-treated mice (50, 100 and 150 mg/kg of bw) and OGTT in alloxan-treated rats (150 mg/kg of bw). Dose of compounds <bold>11</bold> and <bold>12</bold> for AHT was 50 mg/kg of bw [<xref rid="B17-molecules-25-04145" ref-type="bibr">17</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>11</bold>
<sup>(50 mg/kg)</sup>
<break/>
<bold>12</bold>
<sup>(50 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ageratina petiolaris/</italic>Aqu-<break/>eous (<bold>WE</bold>) and methanol (<bold>ME</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold>: AHT (40 and 160 mg/kg of bw), OGTT (160 mg/kg bw); PTT (160 mg/kg of bw) in STZ-NA-treated rats. <bold>ME</bold>: AHT (67 and 268 mg/kg of bw) in STZ-NA-treated rats. Dose of <bold>14</bold> for AHT was 3.73 mg/kg of bw [<xref rid="B18-molecules-25-04145" ref-type="bibr">18</xref>].<break/>In vitro: <bold>WE</bold>: G6Pase Activity (IC<sub>50</sub> = 223 &#x003bc;g/mL) [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
<sup>(56 &#x003bc;g/mL)</sup>
<break/>
<bold>14</bold>
<sup>(3.73 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Annona cherimola/</italic>Etha-nol extract (<bold>EE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>EE</bold>: AHT, CHT in healthy and alloxan-treated rats; OGTT and OSTT in Normoglycemic rats at a dose of 300 mg/kg of bw for the extract and 30 mg/kg of bw for <bold>20</bold> in all experiments (AHT, CHT, OGTT and OSTT); <bold>20</bold> was active in all experiments [<xref rid="B20-molecules-25-04145" ref-type="bibr">20</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>20</bold>
<sup>(30 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Anoda cristata/</italic>Mucil-age (<bold>M</bold>), free mucilage aqueous (<bold>FM-WE</bold>), aqueous (<bold>WE</bold>) and organic (<bold>OE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> and <bold>M</bold> tested in AHT, OGTT, and OSTT in healthy and STZ-NA-treated mice (31.6, 100, and 316 mg/kg of bw). <bold>FM-WE</bold>: AHT, OGTT, and OSTT in healthy and STZ-NA-treated mice (31.6, 100, and 316 mg/kg of bw); OGTT and CHT in metabolic syndrome induced rats (100, and 316 mg/kg of bw). BP: cholesterol, TG, uric acid and glucose. (most active). <bold>OE</bold>: OSTT in healthy and STZ-NA-treated mice (31.6, 56.2, and 100 mg/kg of bw). Doses of <bold>21</bold> and <bold>22</bold> for AHT were 3, 10, and 31.6 mg/kg of bw [<xref rid="B21-molecules-25-04145" ref-type="bibr">21</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>21</bold>
<sup>(3, and 31.6 mg/kg)</sup>
<break/>
<bold>22<sup>(</sup></bold>
<sup>3-31.6 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>21</bold> and <bold>22</bold> are PPAR agonists and antioxidants [<xref rid="B101-molecules-25-04145" ref-type="bibr">101</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Artemisia ludoviciana/</italic>Es-<break/>sential oil (<bold>EO</bold>), organic (<bold>OE</bold>) and aqueous (<bold>WE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>EO</bold>, <bold>OE</bold>, and <bold>WE</bold> tested in AHT, OGTT, and OSTT in healthy and STZ-treated mice (31.6, 100, and 316 mg/kg of bw). Isolated compounds: Cotreatment with Ca2<sup>+</sup> and K<sup>+</sup> ion channels regulators (17.7 mg/kg bw); the doses of <bold>23</bold> and <bold>25</bold> for AHT were 5.6, 17.7, and 31.6 mg/kg of bw.<break/>In vitro: Y-AG for isolated compounds [<xref rid="B22-molecules-25-04145" ref-type="bibr">22</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>23</bold>
<sup>(17.7, 31.6 mg/kg; 0.49 &#x003bc;M)</sup>
<break/>
<bold>24</bold>
<break/>
<bold>25</bold>
<sup>(5.6,17.7 and 31.6 mg/kg)</sup>
<break/>
<bold>26</bold>
<sup>(545.2 &#x003bc;M)</sup>
<break/>
<bold>27</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>23</bold> and <bold>24</bold> lowers blood glucose levels through the up-regulation of GK activity, plasma insulin and adiponectin concentration, downregulated G6Pase and PEPCK activities, and sustained pancreatic &#x003b2;-cell function [<xref rid="B102-molecules-25-04145" ref-type="bibr">102</xref>,<xref rid="B103-molecules-25-04145" ref-type="bibr">103</xref>]. <bold>27</bold>: inhibits AG [<xref rid="B104-molecules-25-04145" ref-type="bibr">104</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Arracacia tolucensis/</italic>Hex-ane (<bold>HE</bold>), ethyl acetate (<bold>EAE</bold>) and ethanol (<bold>EE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>HE, EAE</bold>, <bold>EE</bold>: CHT (250 mg/kg of bw). Hematic biometry and BP: urea, creatinine, cholesterol, TG, HDL, LDL, VLDL, AST, ALT, and bilirubin; <bold>EAE</bold> was the most active) [<xref rid="B23-molecules-25-04145" ref-type="bibr">23</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no compounds were tested in this experiment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Brickellia veronicaefolia/</italic><break/>Essential oil (<bold>EO</bold>), chloroform (<bold>CHE</bold>) and organic (<bold>OE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>OE</bold> and <bold>EO</bold>: AHT, OGTT in healthy and STZ-NA-treated mice (<bold>OE</bold> doses: 30, 100, and 300 mg/kg of bw; <bold>EO</bold> doses: 10 mg/kg of bw). <bold>CHE</bold>: isolation of compounds for testing in AHT in healthy and alloxan-treated mice. The doses of <bold>30</bold> for AHT were 10, 25, and 50 mg/kg of bw [<xref rid="B24-molecules-25-04145" ref-type="bibr">24</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>30</bold>
<sup>(50 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bromelia karatas/</italic>Ethanol:water (<bold>EWE</bold>), aqueous (<bold>WE</bold>) and organic (<bold>OE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (35 and 350 mg/kg of bw), CHT (218 mg/kg of bw) and PTT (218 mg/kg) in STZ-NA rats. <bold>EWE</bold> in AHT (30 and 350 mg/kg of bw) in STZ-NA rats. BP: HbA1c, HDL, TG and cholesterol. The doses of <bold>31</bold>, <bold>3</bold> and <bold>32</bold> for AHT were 72, 3.63, and 1.8 mg/kg of bw, respectively [<xref rid="B26-molecules-25-04145" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-04145" ref-type="bibr">27</xref>].<break/>In vitro: G6Pase Activity [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>31</bold>
<sup>(72 mg/kg)</sup>
<break/>
<bold>32</bold>
<sup>(1.8 mg/kg)</sup>
<break/>
<bold>3</bold>
<sup>(3.63 mg/kg)</sup>
<break/>
<bold>33</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>31</bold> and <bold>33</bold> have hypoglycemic effects in STZ-NA rats treated with doses of 0.25 and 0.50 mg/kg for 21 days to improve biochemical and hematological parameters [<xref rid="B105-molecules-25-04145" ref-type="bibr">105</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Calea oliveri/</italic>Aqueo-us extract (<bold>WE</bold>) and essential oil (<bold>EO</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT, OGTT, and OSTT in healthy and STZ-NA mice (dose of 56, 100, and 316 mg/kg of bw for all experiments). <bold>EO</bold>: OSTT (31.6, 100 and 316 mg/kg of bw). The dose of <bold>39</bold> for OSTT were 5.6, 10, and 31.6 mg/kg of bw; the dose of both <bold>42</bold> and <bold>43</bold> for OSTT were 3.16, 7 and 10 mg/kg of bw. <break/>In vitro: Y-AG for <bold>WE</bold> (IC<sub>50</sub> = 0.169 mg/mL) and isolated compounds [<xref rid="B28-molecules-25-04145" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-04145" ref-type="bibr">29</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>21</bold>
<break/>
<bold>27</bold>
<break/>
<bold>39</bold>
<sup>(5.6-31.6 mg/kg)</sup>
<break/>
<bold>40</bold>
<sup>(0.42 mM)</sup>
<break/>
<bold>41</bold>
<break/>
<bold>42</bold>
<sup>(3.16-10 mg/kg)</sup>
<break/>
<bold>43</bold>
<sup>(3.16-10 mg/kg; 0.28 mM)</sup>
<break/>
<bold>45</bold>
<sup>(0.16 mM)</sup>
<break/>
<bold>46</bold>
<break/>
<bold>47</bold>
<sup>(0.53 mM)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>46</bold> Restores PA-induced loss of &#x003b2;-cell mass and function through AMPK/mTOR-mediated autophagy [<xref rid="B106-molecules-25-04145" ref-type="bibr">106</xref>]; inhibits AG [<xref rid="B107-molecules-25-04145" ref-type="bibr">107</xref>]. <bold>45</bold> and <bold>47</bold> Increase glucose uptakes in skeletal muscle by activating the JAK/STAT pathway, and by CaMKK&#x003b2;/AMPK and insulin signalling pathways, respectively [<xref rid="B108-molecules-25-04145" ref-type="bibr">108</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cecropia obtusifolia/</italic>But-anol (<bold>BE</bold>) and aqueous (<bold>WE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (90 and 150 mg/kg of bw) in STZ-treated rats. CHT in diagnosed type 2 diabetic patients. BP: Serum glucose, cholesterol, TG and insulin levels were determined every 15 days; HbA1c, ALT, AST, and ALKP measured every month. <bold>BE</bold>: AHT (9 and 15 mg/kg of bw), OMTT (96 mg/kg of bw) in STZ-NA-treated rats. The dose of both <bold>13</bold> and <bold>54</bold> for AHT were 10 mg/kg of bw).<break/>In vitro: Y-AG for <bold>BE</bold> (IC<sub>50</sub> =14 &#x003bc;g/mL); adipogenesis and 2-NBDglucose uptake in 3T3-F442A murine adipocytes [<xref rid="B30-molecules-25-04145" ref-type="bibr">30</xref>,<xref rid="B31-molecules-25-04145" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
<sup>(10 mg/kg)</sup>
<break/>
<bold>54</bold>
<sup>(10 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>54</bold> Inhibits AG [<xref rid="B109-molecules-25-04145" ref-type="bibr">109</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cochlospermum vitifolium/</italic>Hex-<break/>ane (<bold>HE</bold>), dichlorometh-ane (<bold>DE</bold>) and methanol (<bold>ME</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>HE</bold> and DE assay in AHT (120 mg/kg of bw) in healthy and STZ-NA-treated rats. <bold>ME</bold>: in AHT (100 mg/kg of bw), OGTT (100 mg/kg of bw), CHT (100 mg/kg of bw) in healthy and STZ-NA-treated rats. BP: Glucose, total cholesterol, HDL and TG.<break/>In vitro: Hepatoprotective activity assay and RI-AG for <bold>ME</bold> (IC<sub>50</sub> = 1.9 mg/ML) [<xref rid="B34-molecules-25-04145" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-04145" ref-type="bibr">35</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>55</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>55</bold> Could prevent functional changes in vascular reactivity in diabetic rats through nitric oxide- and no prostaglandin-dependent pathways [<xref rid="B110-molecules-25-04145" ref-type="bibr">110</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Coriandrum sativum/</italic>Aque-ous extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in OSTT (100, 300, and 500 mg/kg of bw) in healthy rats. The dose of <bold>20</bold> for OSTT was 50 mg/kg of bw).<break/>In vitro: Y-AG for <bold>WE</bold> (IC<sub>50</sub> = 1.63 mg/mL) [<xref rid="B36-molecules-25-04145" ref-type="bibr">36</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>20</bold>
<sup>(50 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cucurbita ficifolia/</italic>Juice (<bold>J</bold>) and aqueous (<bold>WE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>J</bold> tested in AHT (4ml/kg) in Type 2 diabetic patients with moderate hyperglycemia; AHT (125, 250, 500, 594.49, 750, 1000, and 1250 mg/kg of bw) and CHT (1000 mg/kg of bw) in healthy and alloxan-treated mice. <bold>EW</bold>: CHT (200 mg/kg of bw) in STZ-treated mice [<xref rid="B37-molecules-25-04145" ref-type="bibr">37</xref>,<xref rid="B39-molecules-25-04145" ref-type="bibr">39</xref>,<xref rid="B41-molecules-25-04145" ref-type="bibr">41</xref>].<break/>In vitro: Effect on [Ca2<sup>+</sup>]i in RINm5F cells. Viability assays using DRAQ7&#x02122; probe. Participation of <italic>C. ficifolia</italic> as regulator of [Ca2<sup>+</sup>]i through K<sup>+</sup> ATP channels [<xref rid="B40-molecules-25-04145" ref-type="bibr">40</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Equisetum myriochaetum/</italic>Aqueous (<bold>WE</bold>) and<break/>butanol (<bold>BE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> and <bold>BE</bold> assayed in AHT (7 and 13, 8 and 16 mg/kg of bw for <bold>WE</bold> and <bold>BE,</bold> respectively) in STZ-treated rats. <bold>WE</bold> tested in AHT (330 mg/kg of bw) in type 2 diabetic patients. BP: Glucose, TG, cholesterol, and glycated hemoglobin. OMTT (96 mg/kg of bw) and PTT (330 mg/kg of bw) in STZ-treated rats. Dose not reported for <bold>62</bold> in AHT.<break/>In vitro: G6Pase activity and Y-AG for <bold>WE</bold> [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>,<xref rid="B43-molecules-25-04145" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-04145" ref-type="bibr">44</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>62</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eysenhardtia platycarpa/</italic>Met-hanol extract (<bold>ME</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>ME</bold> tested in AHT (30, 100, and 300 mg/kg of bw) in STZ-treated rats. The doses of <bold>69</bold> for AHT were 3.1, 10, and 31 mg/kg of bw [<xref rid="B45-molecules-25-04145" ref-type="bibr">45</xref>,<xref rid="B46-molecules-25-04145" ref-type="bibr">46</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>69</bold>
<sup>(31 mg/kg)</sup>
<break/>
<bold>2</bold>
<break/>
<bold>70</bold>
<break/>
<bold>34</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>70</bold> Acts as hypoglycemic and anti-obesity agent mainly through reducing the absorption of glucose, decreasing endogenous glucose production, increasing insulin sensitivity, improving lipid homeostasis, and weight regulation [<xref rid="B111-molecules-25-04145" ref-type="bibr">111</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eysenhardtia polystachya/</italic>A-queous (<bold>WE</bold>) and<break/>methanol: water (<bold>MWE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT in alloxan-treated mice. <bold>MWE</bold> in AHT (100, 200, and 400 mg/kg of bw) in STZ-treated mice; CHT (400 mg/kg of bw) in STZ-treated mice; OGTT (400 mg/kg of bw) in normal and STZ-treated mice. Compound <bold>104</bold>: Tested in experimental diabetic nephropathy model to study pathological changes in the kidney (dose: 100 mg/kg of bw) [<xref rid="B47-molecules-25-04145" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-04145" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-04145" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-04145" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-04145" ref-type="bibr">51</xref>].<break/>In vitro: <bold>MWE</bold> tested for determining advanced glycation end-product formation [<xref rid="B50-molecules-25-04145" ref-type="bibr">50</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>93</bold>
<break/>
<bold>96</bold>
<break/>
<bold>99</bold>
<break/>
<bold>102</bold>
<break/>
<bold>104</bold>
<sup>(100 mg/kg)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Exostema caribaeum</italic>/Aq-ueous extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT and OSTT in healthy and STZ-NA-treated mice. Doses of 100, 300, and 500 mg/kg of bw for all experiments [<xref rid="B52-molecules-25-04145" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
<break/>
<bold>106</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hamelia patens/</italic>Ethanol:water (1:1) (<bold>EWE</bold>), aqueous (<bold>WE</bold>) and methanol (<bold>ME</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>EWE</bold> and <bold>WE</bold> tested in AHT (30 and 300 mg/kg of bw, and 60 and 600 mg/kg of bw for <bold>EWE</bold> and <bold>WE,</bold> respectively) in STZ-NA-treated rats. <bold>ME</bold> assayed <bold>in</bold> CHT (35, 75 and 150 mg/kg of bw) in healthy and STZ-treated rats [<xref rid="B53-molecules-25-04145" ref-type="bibr">53</xref>,<xref rid="B54-molecules-25-04145" ref-type="bibr">54</xref>].<break/>In vitro: Y-AG for <bold>ME</bold> (IC<sub>50</sub> = 78.3 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
<break/>
<bold>47</bold>
<break/>
<bold>2</bold>
<break/>
<bold>112</bold>
<break/>
<bold>113</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>112</bold> Exhibits significant potential as an antidiabetic agent by suppressing the progression of type 2 diabetic states that is suggested by attenuation of hepatic glucose output and enhancement of adipocyte glucose uptake, insulin secretion, and antioxidant capacity [<xref rid="B112-molecules-25-04145" ref-type="bibr">112</xref>]. <bold>113</bold> improves insulin sensitivity in high fat diet-fed mice and inhibits AG [<xref rid="B113-molecules-25-04145" ref-type="bibr">113</xref>,<xref rid="B114-molecules-25-04145" ref-type="bibr">114</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hintonia latiflora/</italic>Orga-<break/>nic (<bold>OE</bold>) and aqueous (<bold>WE</bold>) and endophytic fungus extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>OE</bold> tested in AHT (10, 30, 100, and 300 mg/kg of bw) in healthy and STZ-treated rats. In CHT (50 and 100 mg/kg of bw) in STZ rats. The doses of compounds <bold>106</bold>-<bold>109</bold> and <bold>114</bold>-<bold>117</bold> for CHT were 15 and 30 mg/kg of bw. <bold>WE</bold> tested in AHT (100, 300 and 500 mg/kg of bw), OSTT (100, 300, and 500 mg/kg of bw) in healthy and STZ-NA-treated rats. The doses of <bold>122</bold> for AHT and OSTT were 3.1, 10, and 31.6 mg/kg of bw [<xref rid="B55-molecules-25-04145" ref-type="bibr">55</xref>,<xref rid="B56-molecules-25-04145" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-04145" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-04145" ref-type="bibr">58</xref>,<xref rid="B115-molecules-25-04145" ref-type="bibr">115</xref>]. The doses of <bold>116</bold> for OSTT was 50 mg/kg of bw.<break/>In vitro: Determination of hepatic glycogen, Y-AG for compounds.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>106</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>107</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>108</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>109</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>115</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>116</bold>
<sup>(30 mg/kg)</sup>
<break/>
<bold>120</bold>
<sup>(23.8 &#x003bc;M)</sup>
<break/>
<bold>121</bold>
<sup>(15.8 &#x003bc;M)</sup>
<break/>
<bold>122</bold>
<sup>(AHT: 31.6mg/kg; OSTT:10 mg/kg; 22.1 &#x003bc;M)</sup>
<break/>
<bold>13</bold>
<break/>
<bold>118</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hintonia standleyana</italic>/Or-ganic extract (<bold>OE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>OE</bold> tested in AHT (10 and 100 mg/kg of bw) in healthy and STZ-treated rats; CHT (50 and 100 mg/kg of bw) in STZ rats and developing hyperglycemic situation in rats. The doses of compounds <bold>115, 116, 123</bold>, and <bold>124</bold> for AHT were 10 mg/kg of bw. The doses of both <bold>115</bold> and <bold>116</bold> for CHT were 15 and 30 mg/kg of bw [<xref rid="B56-molecules-25-04145" ref-type="bibr">56</xref>,<xref rid="B59-molecules-25-04145" ref-type="bibr">59</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>115</bold>
<sup>(15 mg/kg)</sup>
<break/>
<bold>116</bold>
<sup>(15 mg/kg)</sup>
<break/>
<bold>123</bold>
<sup>(10 mg/kg)</sup>
<break/>
<bold>124</bold>
<sup>(10 mg/kg)</sup>
<break/>
<bold>109</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ibervillea sonorae/</italic>Aque-ous (<bold>WE</bold>), juice (<bold>J</bold>),<break/>Dichlorometh-ane (<bold>DE</bold>) and methanol (<bold>ME</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: extracts tested in AHT in healthy and alloxan-treated mice (<italic>ip</italic> administration; the doses of <bold>WE</bold> were 150, 300, 600, and 850mg/kg of bw; dose for <bold>J</bold>, <bold>DE</bold>, and <bold>ME</bold>: 300 and was 600 mg/kg of bw). <bold>WE</bold>: Tested in a murine model of obesity and hyperglycemia, induced by a high-calorie diet; the relationship of these effects with hepatic oxidation were observed.<break/>In vitro: <bold>WE</bold> was assayed for glucose uptake in insulin- sensitive, and insulin-resistant murine and human cultured adipocytes; both in the absence or the presence of insulin signaling pathway inhibitors, and on murine and human adipogenesis [<xref rid="B60-molecules-25-04145" ref-type="bibr">60</xref>,<xref rid="B61-molecules-25-04145" ref-type="bibr">61</xref>,<xref rid="B62-molecules-25-04145" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-04145" ref-type="bibr">63</xref>,<xref rid="B64-molecules-25-04145" ref-type="bibr">64</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ipomoea pes-caprae</italic>/hexane (<bold>HE</bold>) and chloroform (<bold>CHE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: Y-AG of isolated compounds [<xref rid="B65-molecules-25-04145" ref-type="bibr">65</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>142</bold>
<sup>(626 &#x003bc;M)</sup>
<break/>
<bold>144</bold>
<sup>(724 &#x003bc;M)</sup>
<break/>
<bold>155</bold>
<sup>(1067 &#x003bc;M)</sup>
<break/>
<bold>159</bold>
<sup>(330 &#x003bc;M)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Justicia spicigera/</italic>Etha-<break/>nol extract (<bold>EE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>EE</bold> tested in OSTT (100 mg/kg of bw) in healthy and STZ-NA-treated rats. Effect on the glucose uptake in insulin-sensitive and insulin-resistant murine 3T3-F442A and human subcutaneous adipocytes [<xref rid="B66-molecules-25-04145" ref-type="bibr">66</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>169</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>169</bold> Induces hypoglycemic effect in normal and in alloxan-induced diabetic rats; inhibits GLUT4 mediated glucose uptake in differentiated 3T3-L1 cells by interfering with the insulin signaling pathway, and by directly interacting with membrane GLUT4 [<xref rid="B116-molecules-25-04145" ref-type="bibr">116</xref>,<xref rid="B117-molecules-25-04145" ref-type="bibr">117</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ligusticum porteri/</italic>Organic extract (<bold>OE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>OE</bold> tested in AHT, OGTT, and OSTT in healthy and STZ-NA mice; the doses were 56.2, 100, and 316 mg/kg of bw for all experiments. The doses of <bold>170</bold>&#x02013;<bold>171</bold> for OGTT were 10, 31.2 and 56.2 mg/kg of bw for all compounds. The doses of <bold>172</bold> for OSTT were 10 and 56.2 mg/kg of bw.<break/>In vitro: Y-AG for isolated compounds [<xref rid="B67-molecules-25-04145" ref-type="bibr">67</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>171</bold>
<sup>(10-56.2 mg/kg)</sup>
<break/>
<bold>172</bold>
<sup>(10 and 56.2 mg/kg; 2.5 mM)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Melampodium perfoliatum/</italic>Aq-ueous extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: OSTT in STZ-NA-treated mice for isolated compound <bold>175</bold> (doses: 3.16, 10 and 31.6 mg/kg of bw).<break/>In vitro: RI-AG for extract (IC<sub>50</sub> = 985.2 &#x000b5;g/mL) and isolated compound [<xref rid="B68-molecules-25-04145" ref-type="bibr">68</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>175</bold>
<sup>(3.16-31.6 mg/kg; 6.5 mM)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mosannona depressa</italic>/Aqu-eous (<bold>WE</bold>), butanol (<bold>BE</bold>) and ethanol (<bold>EE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: AHT in STZ-treated rats for <bold>WE</bold> (40 and 80 mg/kg of bw), <bold>EE</bold> (113 mg/kg of bw) and <bold>BE</bold> (80 mg/kg bw); the last one was the most active. <bold>BE</bold> tested in OMTT (96 mg/kg of bw) and CHT (50 mg/kg of bw) in STZ-treated rats; and stimulation of insulin secretion in STZ-treated rats; BP measuring glucose, TG, cholesterol, and glycosylated hemoglobin were measured. <bold>EE</bold>: PTT (60 and 80 mg/kg of bw) in n5-STZ rats after an 18-h fasting period.<break/>In vitro: Effect on glucose-6-phosphatase activity for <bold>EE</bold> (IC<sub>50</sub>= 267.62 &#x003bc;g/mL) and Y-AG for <bold>BE</bold> (IC<sub>50</sub>= 267.62 &#x003bc;g/mL) [<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>,<xref rid="B69-molecules-25-04145" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-04145" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-04145" ref-type="bibr">71</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Opuntia streptacantha/</italic>Li-quefied (<bold>LE</bold>) filtrate extract (<bold>FE</bold>) and juice (<bold>J</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>LE</bold> tested in AHT (135 mg/kg of bw) and MTT (135 mg/kg of bw) in n5-STZ rats. <bold>FE</bold>: in AHT (12 and 27 mg/kg of bw) and MTT (12 and 27 mg/kg of bw) in n5-STZ rats. <bold>J</bold> in MTT (4 mL/kg) in n5-STZ rats.<break/>In vitro: RI-AG [<xref rid="B72-molecules-25-04145" ref-type="bibr">72</xref>,<xref rid="B73-molecules-25-04145" ref-type="bibr">73</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Psacalium decompositum/</italic>Aqueous (<bold>WE</bold>), methanol (<bold>ME</bold>) and hexane (<bold>HE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (50, 100, 200, or 400 mg/kg of bw) in healthy and alloxan mice; in OGTT (dose not specified) in healthy rabbits; CHT (150 mg/kg of bw) in rats with 12 weeks fructose feeding. <bold>ME</bold> and <bold>HE</bold> tested in AHT (50, 100, 200, or 400 mg/kg of bw for both extracts) in healthy mice. The doses of <bold>180</bold>-<bold>183</bold> for AHT were 50 and 100 mg/kg of bw [<xref rid="B74-molecules-25-04145" ref-type="bibr">74</xref>,<xref rid="B75-molecules-25-04145" ref-type="bibr">75</xref>,<xref rid="B76-molecules-25-04145" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-04145" ref-type="bibr">77</xref>].<break/>In vitro: Compounds tested in diazoxide-induced relaxation of male rat aortic rings precontracted with phenylephrine.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>180</bold>
<break/>
<bold>182</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Psacalium paucicapitatum</italic> Aqueous extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in CHT and OGTT in mice with 12 weeks fructose feedings [<xref rid="B78-molecules-25-04145" ref-type="bibr">78</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Phoradendron reichenbachianum/</italic>Acetone extract (<bold>AE</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>AE</bold> tested in AHT (100 mg/kg of bw) in STZ-NA rats. CHT, OGTT, and OSTT for isolated compounds in STZ-NA rats (the doses of all the compounds tested were 50 mg/kg of bw) [<xref rid="B79-molecules-25-04145" ref-type="bibr">79</xref>,<xref rid="B80-molecules-25-04145" ref-type="bibr">80</xref>,<xref rid="B81-molecules-25-04145" ref-type="bibr">81</xref>].<break/>In vitro: Inhibitory activity of compounds against protein tyrosine phosphatase1B (PTP-1B). Assay for 11&#x003b2;-HSD1 inhibition [<xref rid="B79-molecules-25-04145" ref-type="bibr">79</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>188</bold>
<sup>(50 mg/kg)</sup>
<break/>
<bold>189</bold>
<sup>(50 mg/kg)</sup>
<break/>
<bold>70</bold>
<sup>(50 mg/kg)</sup>
<break/>
<bold>118</bold>
<sup>(50 mg/kg)</sup>
<break/>
<bold>21</bold>
<break/>
<bold>34</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>34</bold> Attenuates insulin resistance in adipose tissue via IRS-1/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats [<xref rid="B118-molecules-25-04145" ref-type="bibr">118</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rhizophora mangle/</italic>Aque-ous (<bold>WE</bold>) and ethanol:water (<bold>EW</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (5.9 and 59 mg/kg of bw), OMTT (56 mg/kg of bw) in STZ-NA-treated rats. <bold>EW</bold> assayed in AHT (9 and 90 mg/kg of bw), CHT (90 mg/kg of bw) and PTT (90 mg/kg) in healthy and STZ-NA rats [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B82-molecules-25-04145" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-04145" ref-type="bibr">83</xref>,<xref rid="B84-molecules-25-04145" ref-type="bibr">84</xref>].<break/>In vitro: G6Pase activity for <bold>EW</bold> (IC<sub>50</sub>= 99 &#x003bc;g/mL) and RI-AG [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B32-molecules-25-04145" ref-type="bibr">32</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>113</bold>
<break/>
<bold>204</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>204</bold> Induces insulin secretion in vitro and in vivo [<xref rid="B119-molecules-25-04145" ref-type="bibr">119</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salvia circinnata/</italic>Aqu-eous extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT, OGTT, and OSTT in healthy and STZ-NA-treated mice. Doses of 31.6, 100 and 316 mg/kg of bw for all experiments.<break/>The doses for <bold>213</bold> and <bold>214</bold> for OSTT were 3.1, 10, and 31.6 mg/kg of bw, and 1, 3.1, and 10 mg/kg of bw, respectively.<break/>In vitro: RI-AG [<xref rid="B85-molecules-25-04145" ref-type="bibr">85</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>208</bold>
<sup>(39 &#x003bc;M)</sup>
<break/>
<bold>213</bold>
<sup>(3.1-31.6 mg/kg; 500 &#x003bc;M)</sup>
<break/>
<bold>214</bold>
<sup>(1-10 mg/kg; 810 &#x003bc;M)</sup>
<break/>
<bold>215</bold>
<sup>(200 &#x003bc;M)</sup>
<break/>
<bold>216</bold>
<sup>(1800 &#x003bc;M)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Smilax aristolochiifolia/</italic>Acetone (<bold>AE</bold>), ethanol:water (<bold>EWE</bold>) and aqueous (<bold>WE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>AE</bold> and <bold>217</bold> (25 mg/kg of bw) tested in the insulin tolerance curve in mice with a high-caloric diet.<break/>In vitro: Pancreatic &#x003b1;-amylase and Y-AG testing for <bold>WE</bold>, <bold>EWE,</bold> and compounds [<xref rid="B86-molecules-25-04145" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-04145" ref-type="bibr">87</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>217</bold>
<sup>(25 mg/kg)</sup>
<break/>
<bold>13</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Smilax moranensis/</italic>Aq-ueous (<bold>WE</bold>) and ethanol (<bold>EE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (20 and 200 mg/kg of bw) in n5-STZ-treated rats. <bold>EE</bold> assayed in AHT (8 and 80 mg/kg of bw), CHT (80 mg/kg of bw), PTT (80 mg/kg of bw), MTT (80 mg/kg of bw) in healthy and STZ-NA rats; and BP measuring glycated hemoglobin (HbA1c) and lipid profile (HDL, TG and cholesterol).<break/>In vitro: G6Pase activity for EE (IC<sub>50</sub> = 84 &#x003bc;g/mL) and Y-AG [<xref rid="B19-molecules-25-04145" ref-type="bibr">19</xref>,<xref rid="B84-molecules-25-04145" ref-type="bibr">84</xref>,<xref rid="B88-molecules-25-04145" ref-type="bibr">88</xref>,<xref rid="B89-molecules-25-04145" ref-type="bibr">89</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
<sup>(63 &#x003bc;g/mL)</sup>
<break/>
<bold>219</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>219</bold> Induces effects that might contribute to the protection of &#x003b2; cells in diabetes; it reduces insulin secretion in animals with hyperinsulinemia [<xref rid="B120-molecules-25-04145" ref-type="bibr">120</xref>,<xref rid="B121-molecules-25-04145" ref-type="bibr">121</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Swietenia humilis/</italic>Aqueo-us extract (<bold>WE</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (31.6, 100, and 316 mg/kg of bw) OGTT (31.6, 100, and 316 mg/kg of bw), OSTT (100, 177, and 316 mg/kg of bw) in healthy and STZ-NA-treated mice; OGTT (100 and 316 mg/kg of bw) in metabolic syndrome in Sprague Dawley rats (FF-MS). CHT (100 and 316 mg/kg of bw) in FF-MS-induced rats; BP measuring glucose, TG, total cholesterol and uric acid. The doses of all <bold>221</bold>, <bold>222</bold>, and <bold>224</bold> for AHT and OGTT were 3.16, 10 and 31.6 mg/kg of bw.<break/>In vitro: Measurement of hepatic glycogen content and serum insulin levels. Studies on INSE1, H4IIE and C2C12 cells to assess insulin secretion; glucose uptake and mitochondrial bioenergetics, respectively; and glucose-6-phosphatase inhibition [<xref rid="B90-molecules-25-04145" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-04145" ref-type="bibr">91</xref>,<xref rid="B92-molecules-25-04145" ref-type="bibr">92</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>221</bold>
<sup>(3.16-31.6 mg/kg)</sup>
<break/>
<bold>222</bold>
<sup>(3.16-31.6 mg/kg)</sup>
<break/>
<bold>224</bold>
<sup>(3.16-31.6 mg/kg)</sup>
<break/>
<bold>228</bold>
<sup>(16.27 &#x003bc;M)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tecoma stans/</italic>Aqueous (<bold>WE</bold>) and ethanol:water (<bold>EWE</bold>) extracts.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>WE</bold> tested in AHT (500 mg/kg of bw), CHT (125, 250, and 500 mg/kg of bw), OGTT (500 mg/kg of bw) and OSTT (125, 250, and 500 mg/kg of bw) in healthy and STZ-treated rats.<break/>In vitro: Pancreatic lipase inhibition for <bold>EWE</bold> (30% inhibition) and compounds [<xref rid="B93-molecules-25-04145" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04145" ref-type="bibr">94</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>229</bold>
<sup>(85.03%)</sup>
<break/>
<bold>231</bold>
<sup>(32.83%)</sup>
<break/>
<bold>232</bold>
<sup>(36.29%)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>231</bold> Inhibits alpha glucosidases [<xref rid="B109-molecules-25-04145" ref-type="bibr">109</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Turnera diffusa/</italic>Metha-nol extract (<bold>ME</bold>).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo: <bold>ME</bold> assayed in AHT in normoglycemic and alloxan-treated mice. The doses of <bold>234</bold> for AHT were 1 and 5 mg/kg of bw.<break/>In vitro: Y-AG [<xref rid="B95-molecules-25-04145" ref-type="bibr">95</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>234</bold>
<sup>(1-5mg/kg;</sup>
<break/>
<sup>&#x0003e; 330&#x003bc;g/mL)</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup><bold>AHT:</bold> Acute hypoglycemic test. <bold>OGTT:</bold> Oral glucose tolerance test. <bold>OSTT:</bold> Oral sucrose tolerance test. <bold>OMTT:</bold> Oral maltose tolerance test. <bold>CHT:</bold> Chronic hypoglycemic test. <bold>Y-AG:</bold> Yeast &#x003b1;-glucosidase inhibition. <bold>RI-AG:</bold> Rat intestinal &#x003b1;-glucosidase inhibition. <bold>BP:</bold> Blood Biochemical profile. <bold>PTT:</bold> Pyruvate tolerance test. <sup>2</sup> Active compound with defined mechanism of action: <bold>&#x003b1;-glucosidase;</bold> increasing plasmatic insulin levels; insulin sensitivity; other mechanisms; unknown mechanism of action, (active dose/IC<sub>50</sub>).</p></fn></table-wrap-foot></table-wrap></floats-group></article>